Diabetes Research and Clinical Practice

Hyperinsulinemia is differently regulated in obese versus non-obese African diabetic patients
pp. 107-107(1)
Authors: Gulam-Abbas Z.; Ahren B.

Carriers of an inactivating beta-cell K-ATP channel mutation have normally regulated insulin secretion
pp. 107-107(1)
Authors: Huopio H.; Vauhkonen I.; Komulainen J.; Niskanen L.; Otonkoski T.; Laakso M.

The product of HbA1c and daily urine C-peptide level as an index of insulin resistance
pp. 107-107(1)
Authors: Kajio H.; Ikoma A.; Kasono K.; Namai K.; Kawano M.; Kuroki M.; Kanazawa Y.; Kawakami M.

Moderate lifestyle modification improves insulin sensitivity in type 2 diabetes relatives. A 16-week intervention study
pp. 108-108(1)
Authors: Brekke H.K.; Lenner R.A.; Jansson P.-A.

Insulin resistance and beta cell function in Bermudians with type 2 diabetes
pp. 108-108(1)
Authors: Tan M.H.; Jones D.; Willis B.; Smith G.; Andreou P.

Insulin resistance and beta cell function in aboriginals with type 2 diabetes in Atlantic Canada
pp. 108-108(1)
Authors: Tan M.H.; Reddy S.; Abram J.; Andreou P.; Volder D.

Glucose production during fasting in malaria and healthy subjects; the potential regulatory role of glycogenolysis
pp. 109-109(1)
Authors: Sprangers F.; Van Thien H.; Romijn J.A.; Ackermans M.T.; Sauerwein H.P.

Frequency and severity of insulin resistance in type 2 diabetes
pp. 109-109(1)
Authors: Fischer S.; Koehler C.; Metzler W.; Hanefeld M.

Non-pharmacological primary prevention of type 2 diabetes. Impaired glucose tolerance conversion rate in Spain
pp. 109-109(1)
Authors: Costa B.; Donado A.; Martin F.; Basora M.T.; Pinol J.L.

Effects of smoking on insulin sensitivity, insulin clearance, and time-action profile following regular human insulin
pp. 109-110(2)
Authors: Wise S.D.; Seah E.S.; Yasuda M.; Fisher J.; Sathirakul K.; Aftring P.R.

Relation of insulin to left ventricular mass in non diabetic non hypertensive individuals
pp. 110-110(1)
Authors: Vaccaro O.; Cardoni O.; Cuomo V.; de Simone G.; Laurenzi M.; Mancini M.; Riccardi G.

Determination of pathophysiological phenotypes with varying degrees of glucose tolerance using the combination of C-peptide secretion rate and minimal model analysis
pp. 110-110(1)
Authors: Tokuyama Y.; Sakurai K.-i.; Yagui K.; Hashimoto N.; Saito Y.; Kanatsuka A.

Hydroxyderivatives of dehydroepiandrosterone in metabolic syndrome
pp. 110-111(2)
Authors: Matoulek M.; Svacina S.; Hampl R.; Sulcova J.; Haas T.

Age-related changes in postprandial plasma glucose in type 2 diabetes
pp. 111-111(1)
Authors: Oba K.; Okazaki K.; Suzuki T.; Nakano H.

Follow up results in an outpatient clinic according to the patient's compliance in metabolic syndrome/success and fiasco/
pp. 111-111(1)
Authors: Halmos T.; Suba I.; Kautzky L.

The ratio of IL-12 and IL-10 in patients with Naive type 1 and type 2 diabetes
pp. 111-111(1)
Authors: Malyzhev V.; Anastasij L.; Sakalo E.

Prognostic significance of impaired glucose tolerance (IGT)
pp. 112-112(1)
Authors: Timar R.; Pacuraru S.; Rosu M.; Bacanu G.

Decline of beta-cell function, and insulin requirement, in Africans and Europids with adult onset diabetes
pp. 112-112(1)
Authors: Kalk W.J.; Paiker J.

Improved glucose tolerance and fibrinolysis by an intensive lifestyle intervention in subjects with impaired glucose tolerance
pp. 112-112(1)
Authors: Hamalainen H.; Aunola S.; Rastas M.; Marniemi J.; Tuomilehto J.; Uusitupa M.

Prevalence of abnormal glucose tolerance in a rural population in South India
pp. 112-113(2)
Authors: Cheriyan A.A.; Cheriyan A.; Cheriyan A.A.

Effects of aerobic and resistance exercise on insulin action in the elderly
pp. 113-113(1)
Authors: Kitamura I.; Yamanouchi K.; Tokudome M.; Takeshima N.; Oshida Y.; Sato Y.

Insulin pulsatility in non-insulin dependent diabetes after the intravenous bolus of glucose
pp. 113-113(1)
Authors: Penezic Z.; Ciric J.; Trbojevic B.; Drezgic M.; Zarkovic M.

The differences between type 2 and LADA (type 1) diabetic patients of same age
pp. 113-113(1)
Authors: Andel M.; Kraml P.; Potockova J.; Novak J.; Treslova L.; Richterova A.

Is early detection of type 2 diabetes worthwhile?
pp. 113-114(2)
Authors: Colagiuri S.; Cull C.; Holman R.

Diabetes in the Japanese-Brazilians in Sao Paulo, Brazil: A prospective study
pp. 114-114(1)
Authors: Iochida L.C.; Hamada G.S.

Insulin-treated patients: Epidemiological characteristics
pp. 114-114(1)
Author: Domenech M.I.

Insulin-treated patients: Laboratory tests accessibility and biochemical profile
pp. 114-115(2)
Author: Reche L.

Fundamental complications of diabetes mellitus patients in Kyrgyzstan
pp. 115-115(1)
Authors: Moldobaeva M.S.; Akmatkulova D.A.; Attokurova R.M.; Shekekova J.A.

Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in a community of Costa Rica
pp. 115-115(1)
Authors: Araya L.; Mora C.; Arguedas C.

Epidemiology from mellitus diabetes type 1, patients minor 15 years Costa Rica. 1990-99
pp. 115-115(1)
Authors: Calzada L.; Fuscaldo C.; Artavia E.; Estrada Y.; Jaramillo L.; Arguedas C.; Urroz K.

Analysis of stroke and coronary heart disease in type 2 diabetic patients
pp. 115-116(2)
Authors: Higa M.; Ohnuma S.; Nakanishi K.

Prevalence of diabetic retinopathy and diabetic neuropathy in patients with diabetes mellitus type 2 and diabetic nephropathy
pp. 116-116(1)
Authors: Koselj M.; Koselj-Kajtna M.

Initial epidemiologic observations from the prototype national diabetes surveillance system for Canada
pp. 116-116(1)
Authors: Blanchard J.F.; James R.C.; Osei W.D.; Chapman S.; Svenson L.D.; Noseworthy T.

Microvascular complications among diabetic subjects predominate in the long-term follow up: 15-year retrospective study
pp. 116-116(1)
Authors: Sayeed M.A.; Khanam P.A.; Mahtab H.; Khan A.K.A.

Ischaemic heart disease in type-2 diabetic patients in Bangladesh: BIRDEM DCCS
pp. 117-117(1)
Authors: Kibriya M.G.; Hussain M.S.; Islam M.F.; Farzana A.; Rahman F.; Mahtab H.

Hyperglycemia - a rare metabolic anomaly of malignant lymphoproliferative diseases in children
pp. 117-117(1)
Authors: Serban M.; Bataneant M.; Arghirescu S.; Serban V.

Case fatality rate in a tertiary care centre in South India
pp. 117-117(1)
Authors: Cheriyan A.; Cheriyan A.A.; Cheriyan A.A.

Pancreatic calcification and young lean diabetics of Bangladesh
pp. 117-118(2)
Authors: Khan A.K.A.; Ahmed T.; Islam N.; Ikram Z.; Rahman R.; Mahtab H.

Clustering of fibro-calculus pancreatic diabetes (FCPD) in different regions of Bangladesh
pp. 118-118(1)
Authors: Kibriya M.G.; Sayeed M.A.; Khan A.K.A.

Smoking habits in a diabetic population
pp. 118-118(1)
Authors: Frederiksen A.; Jansen S.; Vibe-Petersen J.; Perrild H.

Leanness & HbA1c in young diabetics of Bangladesh
pp. 118-118(1)
Authors: Ahmed T.; Khan A.K.A.; Pathan F.; Mahtab H.; Rahman R.; Latif Z.A.

Diabetic & metabolic consequences of HIV/AIDS and its therapy in asian indian subjects in Western India
pp. 119-119(1)
Authors: Joshi S.R.; Joshi S.S.; Vagera P.; Shah P.S.; Narayanan T.S.

Predictors of impaired glucose tolerance (IGT) and diabetes in the community diabetes prevention project (CDPP)
pp. 119-119(1)
Authors: Bergenstal R.M.; Weaver T.W.; Leite S.A.O.; Monk A.M.; Upham P.A.; Nelson J.B.; List S.M.

Heterogeneity of diabetes presenting with ketoacidosis
pp. 119-119(1)
Authors: Maldonado M.R.; Garza D.; Rajan A.; Hampe C.; Rodriguez L.; Lermark A.; Balasubramanyam A.

Fasting impaired glucose and impaired glucose tolerance in a Mexican population
pp. 120-120(1)
Authors: Gloria R.G.; Alma Gpe A.M.; Marta R.L.; Acevedo A.G.; Preciado A.L.

Born small and grown big increases risk of death in an Indian village
pp. 120-120(1)
Authors: Joglekar A.A.; Shelgikar K.M.; Rege S.S.; Lubree H.G.; Raut K.N.; Deshpande S.S.; Yajnik C.S.

Incidence of type 1 diabetes mellitus under 15 years in Santiago, Chile. 1993-1997
pp. 120-120(1)
Authors: Carrasco E.; Mondragon A.; Santos J.; Perez F.; Calvillan M.

Prevalence of D.M. in the Northern & Eastern region of Syria
pp. 120-120(1)
Authors: El Bache N.; Abouras H.; Jarwod A.; Hachem M.A.

Global variation in the prevalence of complications in type 1 diabetes of 15-24 years duration. Preliminary results from the DIACOMP sub-project of the WHO DIAMOND study
pp. 121-121(1)
Author: DIACOMP INVESTIGATORS

Global variation in the prevalence of complications in type 1 diabetes of 5-14 years duration. Preliminary results from the DIACOMP sub-project of the WHO DIAMOND study
pp. 121-121(1)
Author: DIACOMP INVESTIGATORS

7-yr incidence of glucose intolerance in a population-based study of Japanese-Brazilians: Preliminary data
pp. 121-121(1)
Authors: Gimeno S.G.A.; Ferreira S.R.G.; Franco L.J.; Iunes M.

Diabetes in an elderly population
pp. 122-122(1)
Authors: Zagury L.; Nalaito E.

High body fat with relatively lower BMI in Asian Indians in Northern India
pp. 122-122(1)
Authors: Dudeja V.; Misra A.; Pandey R.M.; Chaudhary D.; Devi R.

Geographical differences in the prevalence of type-2 diabetes in Sweden
pp. 122-122(1)
Authors: Sandstrom H.; Kadesjo A.; Rolandsson O.; Eriksson J.W.

Changing trend in the epidemicity of diabetes mellitus in an Egyptian village
pp. 122-123(2)
Authors: Reifae M.R.; Bakr A.; Sayed-Ahmed N.A.H.; Abdel Aziz M.Y.; Sleit M.

Obesity: A heavy burden on type 2 diabetes mellitus
pp. 123-123(1)
Authors: Ayata E.; Yumuk V.; Gursu U.; Izmir S.; Samanci T.; Osar Z.; Damci T.; Ozyazar M.; Gorpe U.; Ilkova H.

Diabetes in the Mexican elderly: Prevalence, association with cardiovascular risk factors, cognitive and functional impairment, and mortality: CUPA project
pp. 123-123(1)
Authors: Rodriguez J.S.; Morley J.E.; Reynoso M.T.M.; Medina C.A.S.; Salazar P.S.; Torres N.F.; Cruz E.N.

Looking for the metabolic syndrome in Mexican children from San Luis Potosi
pp. 123-124(2)
Authors: Aradillas C.; Hernandez H.; Tenorio E.; Quibrera R.

Intra urban differences in the prevalence of metabolic syndrome - the chennai urban population study (CUPS)
pp. 124-124(1)
Authors: Mohan V.; Shanthirani C.S.; Deepa R.; Premalatha G.; Sastry N.G.; Saroja R.

Prevalence of known diabetes in urban East Delhi
pp. 124-124(1)
Authors: Verma N.P.S.; Madhu S.V.

Glucose metabolism abnormalities in the adult population from the county Timis - Romania
pp. 124-125(2)
Authors: Timar R.; Rosu M.; Pacuraru S.; Bacanu G.S.

An epidemiological account and cost of diabetes in Saskatchewan, Canada
pp. 125-125(1)
Authors: Junor J.; Osei W.D.; Beck P.; Downey W.; Watson F.

Prognostic factors and mortality rates among diabetic and non-diabetic hospitalized patients in a medical department of a University Hospital in Greece
pp. 125-125(1)
Authors: Giannikopoulos G.; Tsapogas P.; Tentolouris N.; Mouktaroudi M.; Panagidou A.; Katsilambros N.

Diabetes mellitus in dombivli - an urban population study
pp. 125-125(1)
Authors: Iyer R.; Iyer R.; Upasani S.; Baitule M.N.

Diabetes mellitus mortality in Mexico using multiple cause-of-death analysis
pp. 125-126(2)
Authors: Perez-Perez G.F.; Escobedo-de la Pena J.; Lara-Zavala R.; Fernandez-Garate I.H.

Prevalence of type 2 diabetes mellitus in zapoteco and mixe Mexican Indians
pp. 126-126(1)
Authors: Escobedo-de la Pena J.; Chavira-Mejia I.; Silva-Batalla A.; Velasco-Romero X.; Martinez-Bazan L.; Escandon-Romero C.; Cabral-Soto J.; Fernandez-Garate I.H.

Economic impact of multiple insulin injection therapy for type 2 diabetic patients
pp. 126-127(2)
Authors: Kishikawa H.; Wake N.; Ohkubo Y.; Sasahara T.; Araki E.; Sakakida M.; Shichiri M.

Comparison of the prognosis of elderly and non-elderly diabetics after 8-year prospective follow-up study
pp. 127-127(1)
Authors: Goriya Y.; Takizawa S.; Natto M.; Minoru K.

Prevalence of diabetes mellitus type 2 in Asturias (Spain)
pp. 127-127(1)
Authors: Botas P.; Delgado E.; Castano G.; Diaz de Grenu C.; Prieto J.; Diaz-Cadorniga F.J.

Prevalence of undiagnosed diabetes in Asian Indian population - evaluation of the new diagnostic criteria
pp. 127-128(2)
Authors: Marita A.R.; Mokal R.A.; Thakur P.K.; Nair S.R.; Sherigar V.S.

Videocapillaroscopy in diabetes mellitus: Metabolic control and microvascular disease
pp. 128-128(1)
Authors: Halfoun V.L.R.C.; Fernandes T.J.; Victer F.C.; Tavares R.

Autogenic training in noninsulin dependent diabetes mellitus: The influence on oxidative stress, glycoregulation and lipids
pp. 128-128(1)
Authors: Kostic N.D.; Caparevic Z.; Jelic S.D.; Dimkovic S.; Ristic S.M.; Diligenski V.

Oxidative stress in diabetes
pp. 128-128(1)
Authors: Shyamsunder P.; Chitturi S.; Sethi B.K.; Aneez

Multichannel laser doppler evaluation in newly diagnosed type 1 diabetes mellitus
pp. 128-128(1)
Authors: Jasik M.; Karnafel W.; Liebert A.; Juskowa J.; Maniewski R.

Markers of oxidative stress in diabetic patients
pp. 129-129(1)
Authors: Tanganelli I.; Ciccoli L.; Tassi R.; Borgogni P.; Rossi V.; Gistri M.; Pettinari O.; Signorini C.; Marisi M.

Serum prorenin levels determined by newly developed direct method in diabetic patients
pp. 129-129(1)
Authors: Minagawa S.; Kawazu S.; Imai Y.; Ohmura E.; Yazawa M.; Tsuchida A.; Ihara C.; Matsuzaki F.; Tanaka H.; Ishida Y.

Impaired circadian blood pressure variation and plasma homocysteine in type 2 diabetes mellitus patients
pp. 129-129(1)
Authors: Drzewoski J.; Czupryniak L.; Bald E.

2h-BG is a better predictor for all cause mortality than either HbA1c or FPG
pp. 129-130(2)
Authors: Qiao Q.; de Vegt F.; Nijpels G.; Everhard F.; Nissinen A.; Tuomilehto J.; Dekker J.M.; Heine R.J.

Role of growth hormone, IGF-1 and IGFBP3 system in diabetic microangopathy
pp. 130-130(1)
Authors: Abbassy A.A.; Kamel S.S.; Said A.S.; el masry A.A.; El basiony G.E.

Serum and urine L-arginine, nitric ooxide metabolites levels in patients with subclinical and clinical type 1 diabetes
pp. 130-130(1)
Authors: Popova V.V.; Mankovsky B.N.; Lysenko V.A.; Kasynchuk N.N.

Relation between interleukin-6 and homocysteine in type 2 diabetes mellitus
pp. 130-130(1)
Authors: Kolcowa O.; Orowska-Kunikowska E.; Narkiewicz K.; Owczarzak A.; Lysiak-Szydlowska W.

Islet cell antibodies and diabetic angiopathies in elderly diabetes type 2 patients
pp. 131-131(1)
Authors: Vartanian N.L.; Odin V.I.; Zarubajev V.V.; Novik A.A.; Pushkova E.S.; Sominina A.A.

Vascular dysfunction can be restored in patients with IDDM by physical training
pp. 131-131(1)
Authors: Pleiner J.; Fuchsjaeger-Mayrl G.; Francesconi M.; Wiesinger G.F.; Sieder A.E.; Wolzt M.

The relationship of glycation, antioxidant status and oxidative stress to capillary damage in diabetes
pp. 131-131(1)
Authors: Wen Y.; Skidmore J.C.; Porter-Turner M.M.; Rea C.A.; Khokher M.A.; Singh B.M.

Aboriginals with type 2 diabetes have higher atherogenic index of plasma than matched controls
pp. 131-132(2)
Authors: Tan M.H.; Reddy S.; Andreou P.; Abram J.; Volder D.

Atherogenic index of plasma in bermudians with diabetes
pp. 132-132(1)
Authors: Tan M.H.; Jones D.; Willis B.; Smith G.; Andreou P.

Effect of glycemic control and beraprost on serum TNF levels in diabetic subjects
pp. 132-132(1)
Authors: Fujiwara K.; Imamura S.; Yamamoto K.; Kato T.; Kakizawa H.; Makino M.; Oda N.; Sawai Y.; Kato S.; Ito Y.; Itoh M.; Nagasaka A.

Serum fibrinogen concentration in hypertensive type 2 diabetic patients
pp. 132-133(2)
Authors: Pavlopoulos C.A.; Antonopoulos A.P.

Tumour necrosis factor- plasma levels, but not expression by mononuclear cells, is elevated in patients with type 1 diabetes and nephropathy
pp. 133-133(1)
Authors: Masding M.G.; Jones J.R.; Kew S.; Calder P.C.; Sandeman D.D.

Tumour necrosis factor- expression by peripheral blood mononuclear cells in postmenopausal women with type 2 diabetes
pp. 133-133(1)
Authors: Masding M.G.; Jones J.R.; Kew S.; Calder P.C.; Sandeman D.D.

Risk of macrovascular disease in type 1 DM: Effects of intensified insulin treatment
pp. 133-134(2)
Authors: Diem P.; Steffes M.W.; Egger M.; The Cochrane Collaborative Review Group

Advanced glycosilation end products (AGEs) in serum, skin, urine and saliva and its correlation with complications of patients with type 2 diabetes mellitus
pp. 134-134(1)
Authors: Garay S.M.E.; Carlos R.G.J.; Laura N.E.; Kazimierz W.Z.; Manuel M.H.J.; Armando C.R.

Metabolic indices and complications in relation to duration of diabetes - findings of the diabcare-Asia (Singapore) study
pp. 134-134(1)
Authors: Lim H.S.; Chew W.L.S.; Emmanuel S.; Goh L.G.; Lau H.C.; Lee C.H.; Soon P.C.; Tambyah J.; Tan Y.Y.; Thai A.C.; Jorgensen L.N.; Yeo J.P.

Relationship between serum thrombomodulin levels and insulin resistance in type 2 diabetes: A comparison with von willebrand factor
pp. 134-134(1)
Authors: Aso Y.; Takanashi K.; Tayama K.; Inukai T.; Takemura Y.

Hyperinsulinemia and oxidizability of low-density lipoproteins in offsprings of hypertensive parents
pp. 135-135(1)
Authors: Vlasakova Z.; Pelikanova T.; Kazdova L.; Lanska V.

Resistance or reduced sensitivity to aspirin occurs more frequently in diabetic patients and is related to nonenzymatic protein glycosylation
pp. 135-135(1)
Authors: Watala C.; Rozalski M.; Kropiwnicka A.; Golanski J.; Wieclawska B.; Drzewoski J.

Microvasculature changes in human skin with type 1 & type 2 diabetes
pp. 135-135(1)
Authors: Rahman M.T.; Begum H.A.; Poston R.N.; Dyson M.

Micro-Vascular complications in type-2 diabetes in Bangladesh: The diabcare-Asia, Bangladesh project
pp. 135-136(2)
Authors: Kibriya M.G.; Mahtab H.

Flow-Mediated vasoactivity in patients with type 2 diabetes following a meal
pp. 136-136(1)
Authors: Shand B.I.; Scott R.S.; Florkowski C.M.; Reynolds M.A.; Ikram H.

Trends in mortality in type 2 diabetic patients
pp. 136-136(1)
Authors: Dabelea D.; Negrisanu G.; Pacuraru S.; Foica D.; Catana L.; Bacanu G.S.

Descriptive analysis of the diabetic retinopathy, patients with mellitus diabetes type 2 in Costa Rica
pp. 136-136(1)
Authors: Castillo R.; Garcia R.; Arguedas C.; Urroz K.

Erythrocyte proton and electron paths in type 1 diabetes mellitus
pp. 137-137(1)
Authors: Matteucci E.; Cinapri V.; Quilici S.; Forotti G.; Giampietro O.

The ''my knowledge about diabetes'' competition for children
pp. 137-137(1)
Author: Kaloper V.G.

Diabcare Asia - India study diabetes care in India - current status
pp. 137-137(1)
Authors: Kapur A.; Jorgensen L.N.; Moorthi S.R.; Ping Y.J.; Bhoraskar A.; Sathe S.R.; Raheja B.S.; Pendsey S.; Sahay B.K.

The prevalence or diabetes in the adult population of Wenzhou suburban inhabitants
pp. 137-138(2)
Author: Xiaoyun Z.

Promoting empowerment in young people with diabetes: A cross-cultural comparison
pp. 138-138(1)
Authors: Greene A.C.; Tripaldi M.; Chiarelli F.; Newton R.; Morris A.; Greene S.

Campaign to promote general population awareness on undetected diabetes and related risk factors in Spain. Efficacy of different information channels
pp. 138-138(1)
Author: Arana R.

Comparison of diabetic and non-diabetic Scottish populations for prevalence of coronary heart disease and classical risk factors: The DARTS and Scottish MONICA Studies
pp. 138-139(2)
Authors: Emslie-Smith A.M.; Chen R.; Tunstall-Pedoe H.; McAlpine R.; Boyle D.I.R.; Libby G.; Newton R.W.; Morris A.D.

Gender differences in cardiovascular risk factors and outcomes of type 2 diabetic patients seen in primary care in the United Kingdom
pp. 139-139(1)
Authors: Stender M.; Eaton S.; Clark D.; Hopkinson P.

How to develop your diabetes association - a joint experience of a small and a big association
pp. 139-139(1)
Author: The Icelandic Diabetes Association

The agra diabetes prevention intervention study in the offspring of biparental diabetics: Cross section analysis initial data
pp. 139-140(2)
Authors: Hazra D.K.; Gupta A.K.; Gagawar P.K.; Sachan A.; Saxena R.; Gaintait K.; Singhal S.

Activities of Latvian Diabetes Association - ways to implement the principles of empowerment in Latvia (1993-2000)
pp. 140-140(1)
Authors: Freimane G.; Rasa I.

The use of new information technologies and classical means of communication in the work of Latvian diabetes association
pp. 140-140(1)
Authors: Freimane G.; Rasa I.

Prevalence of diabetes mellitus, impaired glucose tolerance and cardiovascular risk factors in the urban adult population of Ribeirao Preto - SP, Brazil
pp. 140-141(2)
Authors: Torquato M.T.C.G.; Montenegro R.M.; Viana L.A.L.; Souza R.A.H.G.; Lanna C.M.; Lucas J.C.B.; Durin C.B.; Foss M.C.

Screening for syndrome-X in Hungary
pp. 141-141(1)
Authors: Hidvegi T.; Hetyesi K.; Jermendy G.

Adapting targeted diabetes-screening guidelines for high-risk native American/Alaska native populations using staged diabetes management
pp. 141-141(1)
Authors: Sundem S.L.; Gohdes D.; Robinson R.; Bradley R.; Simonson G.; Idrogo M.; Raymer T.; Moulton K.; Mazze R.

Partnering with Lions Service Clubs to improve diabetes care in rural communities of Minnesota
pp. 141-142(2)
Authors: Sundem S.L.; Robinson R.; Bradley R.; Simonson G.; Risley R.; Lindeman R.; Beard R.; Beard R.; Mazze R.

Our four meetings - our way to empowerment
pp. 142-142(1)
Authors: Buncevic D.; Drazic M.; Kardum M.; Metelko Z.; Kovacevic R.; Prasek M.

Epidemiology of diabetes and obesity in Turkey
pp. 142-142(1)
Authors: Satman I.; Dinccag N.; Karsidag K.; Sengul A.; Salman F.; Sargin M.; Salman S.; Bastar I.; Tutuncu Y.; Uygur S.; Ozcan C.; Yilmaz T.; The TURDEP Group

The origin of evolution of the Diabetes Wellness and Research Foundation (DWRF)
pp. 142-142(1)
Authors: Bortz W.M.; Gold K.; Green C.; Gretschel A.

New preventive programs of the Polish Hypertension and Diabetology Society in Gdansk
pp. 142-143(2)
Authors: Zdrojewski T.; Krupa-Wojciechowska B.; Wyrzykowski B.; Semetkowska-Jurkiewicz E.; Januszko W.

Type 2 DM screening programme in the Czech Republic (CR)
pp. 143-143(1)
Author: Perusicova J.

Maltese Canadian diabetes survey
pp. 143-143(1)
Authors: Mihic M.; Vuksan V.; Corey P.; Jenkins D.J.A.; Metelko Z.; Skrabalo Z.; Vidgen E.

Regeneration of Islet -cells by Reg (Regenerating Gene): Transcriptional activation of Reg gene and identification of reg protein receptor
pp. 144-144(1)
Authors: Okamoto H.; Akiyama T.; Kobayashi S.; Nata K.; Ikeda T.; Shervani N.J.; Nakagawa K.; Takasawa S.

Sucrose administration to normal pregnant hamsters induces changes in Islet Neogenesis-Associated Protein (INGAP) - Positive Cell mass in the offspring
pp. 144-144(1)
Authors: Del Zotto H.H.; Massa M.L.; Reifel-Miller A.; Gold G.; Vinik A.; Gagliardino J.J.

Persistent hyperinsulinaemic hypoglycaemia of infancy: A surway for mutations in Danish children with nesidioblastosis
pp. 144-144(1)
Authors: Brusgaard K.; Hansen T.; Barbetti F.; Nielsen H.B.; Jacobsen B.B.

Quantification of the pancreatic beta-cell mass and insulin content in normal and type 2 diabetic subjects in Korea
pp. 144-145(2)
Authors: Son H.-Y.; Yoon K.-H.; Ko S.-H.; Seo S.-H.; Moon S.-D.; Chang S.-A.; Ahn Y.-B.; Kang M.-I.; Cha B.-Y.; Lee K.-W.; Kang S.-K.

Activation of c-Myc in -cellsIn Vivo: Cancer and diabetes - two faces of the same coin
pp. 145-145(1)
Authors: Pelengaris S.; Khan M.; Evan G.

Expression and cellular distribution pattern of plasma membrane calcium pump isoforms and spliced variants in rat pancreatic islets
pp. 145-145(1)
Authors: Gagliardino J.J.; Garcia M.E.; Del Zotto H.H.; Caride A.J.; Rossi J.P.; Filoteo A.G.; Penniston J.T.

Fatty acid-induced attenuation of mouse pancreatic islet calcium-independent phospholipase A₂
pp. 145-146(2)
Authors: Capito K.; Thams P.

Inter- and intramolecular interactions in the assembly of -cell K-ATP channels
pp. 146-146(1)
Authors: Mikhailov M.V.; Ashcroft S.J.H.

IAPP and insulin release from human pancreatic islets - indication of K_ATP-independent IAPP secretion
pp. 146-146(1)
Authors: Karlsson E.; Sandler S.

Differential mechanisms of glucose and saturated fatty acids in augmentation of insulin secretion in mouse pancreatic islets
pp. 146-147(2)
Authors: Thams P.; Capito K.

Lipotoxicity of the pancreatic beta-cell is associated with a glucose-dependent, substrate-driven increase in esterification of fatty acids into neutral lipids
pp. 147-147(1)
Authors: Briaud I.; Harmon J.S.; Kelpe C.L.; Segu V.B.; Poitout V.

Influence of short-term glucocorticoid administration on basal and glucose entrained high frequency insulin pulsatility in healthy
pp. 147-147(1)
Authors: Hollingdal M.; Juhl C.B.; Dall R.; Sturis J.; Porksen N.; Schmitz O.

Possible modulatory effect of endogenous islet catecholamines on insulin secretion
pp. 147-147(1)
Authors: Borelli M.I.; Gagliardino J.J.

The sodium driven chloride bicarbonate exchanger: Cloning, tissue distribution, and functional characterization
pp. 147-148(2)
Authors: Wang C.-Z.; Yano H.; Nagashima K.; Seino S.

Glucose stimulation of transmembrane chloride flux in individual pancreatic -cells demonstrated with a microfluorometric technique
pp. 148-148(1)
Authors: Grapengiesser E.; Eberhardson M.; Patterson S.

Do glucose and glyceraldehyde induce insulin release differently?
pp. 148-148(1)
Authors: Tatsuo T.; Noriki M.; Kazumasa U.; Nigishi H.

Nitric oxide - A putative synchronizer of pancreatic -cell activity
pp. 148-148(1)
Authors: Hellman B.; Grapengiesser E.; Gylfe E.

Mitochondrial ATP production is not the metabolic coupling factor in methyl pyruvate induced membrane depolarization and insulin release
pp. 148-149(2)
Authors: Lembert N.; Joos H.C.; Wahl M.A.; Idahl L.-A.; Ammon H.P.T.

The role of Ca²⁺-channels within the mode of action of electrical activity induced by methylpyruvate
pp. 149-149(1)
Authors: Joos H.C.; Lembert N.; Ammon H.P.T.; Wahl M.A.

Functional effect of metabotropic glutamate and GABA receptors on Insulin Secretion
pp. 149-149(1)
Authors: Brice N.L.; Molnar E.; Ashcroft S.J.H.

Glucose-induced apoptosis in pancreatic beta (HIT) cells
pp. 149-149(1)
Authors: Wang Z.-X.; Waddell I.D.; Marcelli M.; Rajan A.S.

Involvement of protein kinase C in cholinergic potentiation of glucose-induced 5-HT/insulin secretion
pp. 149-150(2)
Authors: Baldeiras I.E.; Barbosa R.M.; Santos R.M.; Rosario L.M.

Lack of bursting electrical activity and intracellular calcium oscillations in glucose-stimulated single rat islets
pp. 150-150(1)
Authors: Antunes C.M.; Salgado A.P.; Rosario L.M.; Santos R.M.

Lack of induction of 8-oxoguanine following cytokine treatment of wistar rat islets
pp. 150-150(1)
Authors: Rosales Hernandez A.L.; Green M.H.L.; Cunningham J.M.; Bone A.J.

Tumor Necrosis factor- induces apoptosis in an insulin-secreting -cell line
pp. 150-150(1)
Authors: Evgenov N.V.; Paulssen R.H.; Evgenov O.V.; Christiansen I.; Florholmen J.

The porcine rubulavirus LPMV infects rat pancreatic islets resulting in an impairment of glucose stimulated insulin release
pp. 151-151(1)
Authors: Jauregui P.H.; Jacoub A.; Andersson A.; Pimentel A.; Frisk G.; Moreno J.W.

Insulin secretion upon gastric luminal glucose instillation is related to glucose flux across the fundic wall and mediated by the vagus: Evidence for a novel gastro-insular axis
pp. 151-151(1)
Authors: Nakagawa A.; Azuma S.; Nakabayashi H.

What does streptozotocin do in mice?
pp. 151-151(1)
Authors: Axmann G.; Tschoepe C.; Walther T.

Elevated plasma non-esterified fatty acid levels and insulin secretion rates in non-diabetic 1^st degree relatives of type 2 diabetic patients
pp. 151-152(2)
Authors: Butler T.J.; Barriocanal L.A.; Walker M.

Regulation of the JNK signaling pathway and pancreatic -cell apoptosis by the scaffold protein islet-brain 2 (IB2)
pp. 152-152(1)
Authors: Negri S.S.S.; Oberson A.; Steinmann M.; Sauser C.; Nicod P.; Waeber G.; Schorderet D.; Bonny C.

New cell-permeable peptides inhibitors of JNK protect pancreatic -cells from IL-1 induced apoptosis
pp. 152-152(1)
Authors: Bonny C.; Oberson A.; Negri S.; Christelle S.; Schorderet D.F.

Autocrine regulation of insulin secretion by NGF
pp. 152-152(1)
Authors: Hiriart M.; Vidaltamayo R.; Sanchez-Soto C.; Mery C.M.; Jimenez V.; Angeles A.; Robles-Diaz G.

Circadian control of islet-specific genes
pp. 152-153(2)
Authors: Allaman-Pillet N.; Kaltenrieder V.; Mathieu S.; Schorderet D.F.; Bonny C.

Glutamate is not the direct conveyer of K_ATP channel-independent, insulinotropic action of glucose in rat islet cell
pp. 153-153(1)
Authors: Yamada S.; Aizawa T.; Komatsu M.; Sato Y.; Hashizume K.

Effects of uncoupling protein-2 and -3 on mitochondrial respiration and lipid oxidation in INS-1 cells
pp. 153-153(1)
Authors: Hong Y.; Fink B.D.; Joseph D.S.; Sivitz W.I.

Reduction of incretin-like salivatin in saliva from type 2-diabetic patients and in parotid glands of streptozotocin-diabetic BALB/c mice
pp. 153-154(2)
Authors: Kimura I.; Sasamoto H.; Sasamura T.; Sugihara Y.; Ohgaku S.; Kobayashi M.; Kimura M.

Taurine supplementation to the low protein diet of the dam or added in vitro prevents the cytotoxic action of interleukin-1 in fetal rat islet
pp. 154-154(1)
Authors: Remacle C.; Merezak S.; Reusens B.

Streptozotocin increased hydroxyl-radicals in pancreatic islets of mice in vitro
pp. 154-154(1)
Authors: Ohly P.; Gille L.; im Walde S.S.; Nohl H.; Gleichmann H.

Effect of nicotinamide's treatment on ascorbate/dehydroascorbate pools and lipid peroxidation in tissues of streptozotocine diabetic rats
pp. 154-155(2)
Authors: Oliyarnyk O.D.; Biront N.V.; Vygnan T.L.; Velyky M.M.

Studies of mechanisms of diabetogenic action of xanturenic acid
pp. 155-155(1)
Authors: Meyramova A.; Abikenova F.; Kikimbaeva A.; Kohnert K.D.; Meyramov G.

Leptin and high glucose induces cell proliferation in drug sensitive human breast cancer cells (MCF7) but not in multidrug-resistant cells (MCF7/ADR): Possible involvement of the changes of PKC- expression treated with glucose and leptin
pp. 155-155(1)
Authors: Okumura M.; Yamamoto M.; Sakuma H.; Kojima T.; Yasuda K.; Cooper D.R.

Could simple aging process be an inevitable risk factor for insulin insensitivity
pp. 155-155(1)
Authors: Rifaie M.R.; El Kanishi M.H.; Ghareeb N.A.; Sayed-Ahemed N.A.H.; Bakr A.; Aziz M.Y.A.; El-Gawad S.S.A.

Molecular mechanism of hyperinsulinemia-induced degradation of IRS-1
pp. 155-156(2)
Authors: Sun X.J.; Zhande R.

In vivo analysis of insulin signaling pathway in the mouse skeletal muscle, and influence of insulin resistance induced by TNF- and glucosamine
pp. 156-156(1)
Authors: Sakaue M.; Miki T.; Kasuga M.

Increased insulin secretion fails to compensate for insulin resistance in mice with impaired glucose disposal under high-fat diet
pp. 156-156(1)
Authors: Pacini G.; Ahren B.

Positive regulation of insulin receptor signaling by the Grb10 adapter protein
pp. 156-157(2)
Authors: Giovannone B.; Tiller G.; Smith R.J.

Protein tyrosine phosphatase 1B is impaired in skeletal muscle of diabetic psammomys obesus
pp. 157-157(1)
Authors: Ikeda Y.; Ziv E.; Shafrir E.; Mosthaf L.

Redistribution of signaling proteins from caveolae as potential target for insulin-mimetic compounds
pp. 157-157(1)
Authors: Muller G.; Welte S.; Wied S.

The acute and chronic stimulatory effects of endothelin-1 on glucose transport are mediated by distinct pathways in 3T3-L1 adipocytes
pp. 157-157(1)
Authors: Ishibashi K.; Imamura T.; Sharma P.M.; Ugi S.; Olefsky J.M.

Relationship of insulin activation of protein kinase B in human muscle cells with myogenic differentiation but not glucose uptake or glycogen synthesis
pp. 157-158(2)
Authors: Kruetzfeldt J.; Kausch C.; Haering H.U.; Stumvoll M.

GLUT4 gene expression in insulin-resistant obese rats involves post-transcriptional poly-A tail mRNA modulation
pp. 158-158(1)
Authors: Seraphim P.M.; Assis T.G.R.; Volpato C.B.; Nunes M.T.; Machado U.F.

Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes
pp. 158-158(1)
Authors: Ishibashi K.-I.; Imamura T.; Sharma P.M.; Ugi S.; Olefsky J.M.

Cellular insulin resistance decreases osmotic shock-induced glucose transport in 3T3-L1 adipocytes
pp. 158-158(1)
Authors: Janez A.; Sears-Worrall D.; Olefsky J.M.

Long-term insulin exposure impairs glucose uptake and GLUT4 expression in rat adipocytes when the glucose level is high
pp. 159-159(1)
Authors: Buren J.; Lauritz J.; Eriksson J.W.

Impaired insulin signaling pathway in skeletal muscle from subjects with insulinoma
pp. 159-159(1)
Authors: Janez A.; Mrevlje F.; Sharma P.M.; Kocijancic A.

Glucocorticoids induce insulin resistance without decreasing GLUT4 content in primary cultured rat adipocytes
pp. 159-159(1)
Authors: Buren J.; Eriksson J.W.

Glucocorticoid receptor and 2-adrenoreceptor mRNA levels in insulin resistant NIDDM patients. Effects of metabolic control
pp. 159-160(2)
Authors: Vestergaard H.; Bratholm P.; Christensen N.J.

Association between tumor necrosis factor-alpha (TNF-) and correlates of insulin resistance in a cohort of type 2 diabetic patients from West Africa
pp. 160-160(1)
Authors: Furburt-Harris P.M.; Ellison G.L.; Laniyan I.; Gause D.P.; Vaughn T.; Dunston G.M.; Rotimi C.N.; AADM Study Investigators

Effect of bovine somatotropic hormone on insulin response to glucagon-like peptide 1, in dogs
pp. 160-160(1)
Authors: Pierluissi J.; de Pierluissi R.; de Martinez A.; Quero Z.

Mechanisms of altered Ca²⁺ turnover in type 2 diabetes
pp. 160-161(2)
Authors: Balasubramanyam M.; Balaji R.A.; Subashini B.; Mohan V.

Obesity, insulin, leptin resistance and TNF- levels in hGH transgenic rats
pp. 161-161(1)
Authors: San Gabriel A.; Torii K.; Takahashi M.

Low adipocyte IRS-1 expression is associated with both insulin resistance and increased plasma FFA levels in response to stress
pp. 161-161(1)
Authors: Jansson P.-A.; Sandqvist M.; Carvalho E.; Smith U.

Malonyl-CoA decarboxylase expression is activated by fatty acids in cardiac and skeletal muscle
pp. 161-161(1)
Authors: Young M.E.; Goodwin G.W.; Ying J.; Guthrie P.; Taegtmeyer H.

Beta-cell mass and site of pancreatic venous drainage are independent determinants of the suppression of endogenous glucose production and systemic insulin sensitivity during glucose loading
pp. 162-162(1)
Authors: Radziuk J.; Barron P.; Davies J.; Pye S.

Involvement of the nervous system in the control of glucose uptake in contracting hindlimb muscle in the rat
pp. 162-162(1)
Authors: Kusunoki M.; Nakamura T.; Sakakibara F.; Kato K.; Okabayashi N.; Iriyama A.; Usui K.; Yamanouchi K.; Kakumu S.; Storlien L.H.

Hypoglycemia increases skeletal muscle glutamine efflux by reducing glutamine uptake
pp. 162-162(1)
Authors: Meyer C.; Dostou J.; Woerle H.J.; Gerich J.E.

Metabolic handling of intraduodenally compared to intravenously administered glucose in normal subjects
pp. 162-163(2)
Authors: Fery F.; Deviere J.; Balasse E.O.

Insulin sensitivity of glucose transport and glucose disposal during IVGTT
pp. 163-163(1)
Authors: Hovorka R.; Carroll P.V.; Umpleby M.; Chassin L.; Jackson N.C.; Tudor R.S.; Gowrie I.J.; Jones R.H.; Shojaee-Moradie F.

Quantification of gluconeogenesis in a single blood sample by ²H nuclear magnetic resonance spectroscopy
pp. 163-163(1)
Authors: Stingl H.; Krssak M.; Rosian E.; Kunert O.; Zangger K.; Weghuber D.; Nowotny P.; Waldhausl W.; Haslinger E.; Roden M.

Heterogeneity of glucose metabolism at rest and during exercise in obesity as measured using [¹⁸F]-FDG and PET
pp. 163-163(1)
Authors: Larmola K.; Peltoniemi P.; Kemppainen J.; Laine H.; Kalliokoski K.; Yki-Jarvinen H.; Knuuti J.; Nuutila P.

Insulin and exercise stimulated glucose uptake and its heterogeneity in subjects with type 1 diabetes. In vivo studies using [¹⁵O]-H₂O, [¹⁵O]-O₂, [¹⁸F]-FDG and PET
pp. 164-164(1)
Authors: Peltoniemi P.; Yki-Jarvinen H.; Oikonen V.; Ronnemaa T.; Knuuti J.; Nuutila P.

Insulin stimulates glucose uptake and activates protein kinase B in contracting muscles without increasing IRS-1/2 associated PI 3-kinase activity
pp. 164-164(1)
Authors: Jensen J.; Soos M.A.; Aslesen R.; O'Rahilly S.; Whitehead J.P.

Endurance exercise training modulates AKT/PKB phosphorylation in white adipose tissue and skeletal muscle
pp. 164-164(1)
Authors: Peres S.B.; Franzoi^de Moraes S.M.; Borges C.N.; Costa C.M.; Carvalho C.R.O.; Lima F.B.

Susceptibility of insulin-secreting hepatocyte to toxicity of autoimmune cytokines
pp. 164-165(2)
Authors: Tabiin M.T.; Tuch B.E.; Bai L.; Han X.; Simpson A.M.

A disease-associated cellular immune response in type I diabetics to an immunodominant epitope of insulin
pp. 165-165(1)
Authors: Alleva D.G.; Jin L.; Crowe P.D.; Kwok W.W.; Ling N.; Gottschalk M.; Gaur A.; Conlon P.J.

In vivo activation of NKT cells by alpha galactosylceramide prevents autoimmune type I diabetes
pp. 165-165(1)
Authors: Sharif S.; Arreaza G.A.; Delovitch T.L.

Transcriptional upregulation of GAD67 in pancreatic cells by glucocorticoid hormone
pp. 165-165(1)
Authors: Kang Y.; Kim K.-S.; Choi S.E.; Ha M.J.; Kim H.-M.; Jun H.-S.; Yoon J.-W.

Direct evidence on the role of NKT cells in the control of T cell-mediated autoimmune diabetes in NOD mice
pp. 165-166(2)
Authors: Yang Y.; Bao M.; Yoon J.-W.

The role of monocyte chemoattractant peptide (MCP-1) in T-cell-mediated autoimmune diabetes in NOD mice
pp. 166-166(1)
Authors: Jun H.-S.; Park S.; Zbytnuik L.; Yoon J.-W.

Signal transducer and activator of transcription (STAT)4 deficiency, associated with impaired Th1 immune response, reduces sensitivity to multiple low-dose streptozotocin-induced diabetes in STAT4^-/- mice
pp. 166-166(1)
Authors: Cetkovic-Cvrlje M.; Dragt A.L.; Uckun F.M.

Insulitis profile and disease progression in the diabetes-prone BB/S rat
pp. 166-166(1)
Authors: Ratcliff H.; Lally F.J.; Cunningham J.M.; Bone A.J.

Transcriptional expression of Fas and Fas ligand (FasL) in thymus and spleen of NOD mice
pp. 167-167(1)
Authors: Decallonne B.; Overbergh L.; Bouillon R.; Waer M.; Mathieu C.

Lethal shock in 1,25-dihydroxyvitaminD3 treated NOD mice after HEL immunization
pp. 167-167(1)
Authors: Mathieu C.; Decallonne B.; Overbergh L.; Bouillon R.

The expression of the chemokines MIP-1 and MIP-1 differs between male and female NOD-mice. Expression of MIP-1 or MIP-1 alone is not sufficient to induce inflammation
pp. 167-167(1)
Authors: Schiotz L.-K.; Hjorth P.J.; Dagnaes-Hansen F.; Bach L.W.

Anti-CD154 alone prevents autoimmune diabetes in the BBDR rat
pp. 168-168(1)
Authors: Chu W.; Geng Z.; Benjamin C.; Hess D.; Kover K.; Moore W.V.

Maternal type 1 diabetes modifies immunization to dietary insulin in infancy
pp. 168-168(1)
Authors: Paronen J.; Knip M.; Savilahti E.; Virtanen S.M.; Ilonen J.; Åkerblom H.K.; Vaarala O.

Correlation between glutamic acid decarboxylase 65 antibody, IA-2 antibody and HLA-DR genotypes in Japanese patients with type 1 diabetes
pp. 168-168(1)
Authors: Maruyama T.; Kasuga A.; Nakamoto S.; Shimada A.; Matsubara K.; Iwasaki R.; Suzuki Y.; Saruta T.

GADA detection in Immune Mediated Diabetes Mellitus (IMDM) patients by Indirect Immunofluorescence (IIF) using transfected CHO cells expressing recombinant human GAD 65
pp. 169-169(1)
Authors: Iacono R.F.; Labovsky V.; Villalba A.; Valdez S.N.; Villanueva A.L.; Papouchado M.L.; Poskus E.

Persistence of multiple diabetes-associated autoantibodies in normal school children
pp. 169-169(1)
Authors: Strebelow M.; Schlosser M.; Rjasanowski I.; Ziegler B.; Ziegler M.

Predictive diagnostic value of multiple or high titre single autoantibodies to beta-cell antigens is supported by analysis of type 1 diabetes-associated genetic markers in children of a general population
pp. 169-170(2)
Authors: Ziegler M.; Schlosser M.; Strebelow M.; Ziegler B.; Rjasanowski I.; Wassmuth R.

Autoantibodies levels in children and adolescents with Diabetes Mellitus (DM), type I from different region of Belarus
pp. 170-170(1)
Authors: Vorontsova T.; Mokhort T.; Shavrova E.; Karlovitch N.; Kholodova E.; Ostapenko S.

Study of immune tolerance mechanisms of oral administration insulin to NOD female mice
pp. 170-170(1)
Authors: Dong Y.; Hou N.

Cow's milk proteins cause similar Th1- and Th2-like immune response in both diabetic and healthy children
pp. 170-170(1)
Authors: Karlsson M.G.E.; Garcia J.; Ludvigsson J.

Searching for common genetic marker(s) of autoimmune disorders in patients with insulin dependent diabetes mellitus and coeliac disease: Molecules involved in activation of lymphocytes
pp. 171-171(1)
Authors: Witas H.W.; Bodalski J.; Jedrychowska-Danska K.; Sychowski R.; Socha J.

New immunogenetical aspects of type 1 diabetes
pp. 171-171(1)
Authors: Gurbanov T.; Gurbanova G.; Gurbanov T.

Markers of destruction of -cells and apoptotic lymphocytes precomitation in IDDM patients
pp. 171-171(1)
Authors: Mokhort T.V.; Melnov S.B.; Goranov V.A.

Low stress response enhances cell-mediated in vitro lysis of insulin-producing RIN-cells in BB rats
pp. 171-172(2)
Authors: Wanka H.; Wachlin G.; Kuttler B.

In vitro effects of streptozotocin on cytokine profiles in pancreatic islets of mice
pp. 172-172(1)
Authors: Mueller A.; Gleichmann H.

L-selektin, 1-integrin, VLA-4 expressions in autoimmune type 1 diabetic patients with T_H1 pathway activation
pp. 172-172(1)
Authors: Dervogormiyaciyan H.; Arash M.; Aydemir D.; Oksuz L.; Yillar G.; Bilgic S.; Aktas E.; Kiran B.; Deniz G.; Yilmaz M.T.

T_H1 and T_H2 pathway in different clinical stages of autoimmune type 1 diabetes mellitus
pp. 172-172(1)
Authors: Yillar G.; Aydemir D.; Oksuz L.; Arash M.; Aktas E.; Bilgic S.; Gurol A.O.; Deniz G.; Yilmaz M.T.

Changes in memory T cells in pre- and early clinical stages of autoimmune type 1 diabetes with T_H1 pathway activation
pp. 172-173(2)
Authors: Aydemir D.; Arash M.; Yillar G.; Oksuz L.; Bilgic S.; Aktas E.; Gurol A.O.; Deniz G.; Yilmaz M.T.

Production of IL-10 and IL-12 in type 1 diabetic patients with antibodies to GAD
pp. 173-173(1)
Authors: Itoh M.; Uchimura K.; Makino M.; Imamura S.; Yamamoto K.; Kato T.; Fujiwara K.; Nagasaka A.

In diabetes mellitus 2, the autoantibodies are turned negative through autohemoterapy
pp. 173-173(1)
Author: Ramirez J.G.

Relation between cytokine production and age in patients with type 1 diabetes
pp. 173-173(1)
Authors: Klemetti P.; Savilahti E.; Kantele J.M.; Åkerblom H.K.; Vaarala O.

HLA-DQB1 and insulin gene susceptibility to diabetes in fibrocalculus pancreatic diabetes
pp. 174-174(1)
Authors: Hassan Z.; Davey S.; Ali L.; Sinnott P.J.; McDermott M.F.; Khan A.K.A.; Hitman G.A.

Autoantibody and HLA-dependent reduction in residual -cell function
pp. 174-174(1)
Authors: Ortqvist E.; Lynch K.; Schranz D.; Kochum I.; Persson B.; Breslow N.; Lernmark A.

Disease associated vitamin D receptor (VDR) genotypes influence VDR mRNA levels in Bangladeshis
pp. 174-174(1)
Authors: Hitman G.A.; Ogunkolade W.; Bustin S.; Burrin J.; McDermott M.; Boucher B.J.

A rodent model to evaluate the contribution of genes versus intrauterine environment in the development of type 2 diabetes
pp. 174-174(1)
Authors: Gill-Randall R.J.; Alcolado J.C.

Genetic, comparative and physical mapping of the rat autoimmune type I diabetes locus Iddm/kdp1
pp. 175-175(1)
Authors: Yokoi N.; Yasuda K.; Komeda K.; Serikawa T.; Seino S.

Two new rat lines congenic for the diabetes prone BB rat alleles of Iddm1 and Iddm2
pp. 175-175(1)
Authors: Hornum L.; Markholst H.

CTLA-4 gene dimorphism is assoclated with predisposition to type 1 diabetes in a population from Tunisia
pp. 175-175(1)
Authors: Abid H.K.; Smaoui N.; Hmida S.; Abid A.; Chaabouni H.; Blouza S.; Nagati K.

CTLA-4 polymorphisms in Asian Indian patients with type 1 diabetes
pp. 175-175(1)
Authors: Tandon N.; Waterman E.A.; Watson P.F.; Mehra N.K.; Weetman A.P.

A new syndrome? - Diabetes, deafness, premature greying of hair, wolff-parkinson-white and placenta accreta
pp. 176-176(1)
Authors: Agrawal P.; Gill-Randall R.J.; Wheatley T.; Metcalf J.; Alcolado J.C.

The mitochondrial gene variations of type 2 diabetes in Chinese
pp. 176-176(1)
Authors: Ma L.; Wang H.; Chen J.

Analysis of a polycytosine tract and heteroplasmic length variation within the mtDNA D-loop in type 2 diabetes patients
pp. 176-176(1)
Authors: Alcolado J.C.; Sherratt E.J.; Thomas A.W.; Gagg J.W.; Gill-Randall R.J.

Autosomal dominant renal cysts and diabetes (RCAD): A novel syndrome of diabetes and cystic kidney disease resulting from hepatocyte nuclear factor - 1 beta gene mutations
pp. 176-176(1)
Authors: Owen K.; Bingham C.; Ellard S.; Allen L.I.S.; Bulman M.P.; Jones R.W.A.; Woolf A.S.; Nicholls A.J.; Hattersley A.T.

Polymorphic variation of calpain 10 (NIDDM1) and its relationship to type 2 diabetes and intermediate traits in a Southern Indian population
pp. 177-177(1)
Authors: Jackson A.E.; Cassell P.; Ramachandran A.; Snehalatha C.; Hitman G.A.

Genes of antioxidant defence and diadetes mellitus
pp. 177-177(1)
Authors: Dedov I.I.; Chistyakov D.A.; Savost'yanov K.V.; Turakulov R.I.; Kuraeva T.L.; Nosikov V.V.

Missense mutations in the insulin promoter factor-1 gene in a healthy German population are not associated with decreased insulin secretion
pp. 177-177(1)
Authors: Machicao F.E.; Fritsche A.; Stumvoll M.; Weisser M.; Rettig A.; Schleicher E.; Haering H.U.

Failure of compensatory beta-cell hyperplasia in response to insulin resistance plays a crucial role in the development of type 2 diabetes
pp. 177-177(1)
Authors: Terauchi Y.; Komeda K.; Kubota N.; Eto K.; Tsubamoto Y.; Tobe K.; Akanuma Y.; Kadowaki T.

Leucine 7 to proline 7 polymorphism in the neuropeptide Y gene is not associated with cholesterol concentrations or blood pressure in type 2 diabetic subjects
pp. 178-178(1)
Authors: Karvonen M.K.; Koulu M.; Rissanen A.; Pesonen U.; Uusitupa M.I.J.

Porcine endogenous retrovirus C (PERV C) is not transmitted following pig proislet xenotransplantation in foetal lambs
pp. 178-178(1)
Authors: Wilson J.D.; Mann D.; Gibbs A.; McCullagh P.; Simeonovic C.

Lack of toxicity from Fas-Fas ligand interaction in fetal pig pancreatic cells
pp. 178-178(1)
Authors: Bai L.; Tuch B.E.

Prolongation of islet survival by pefloxacin during storage under hypothermic conditions
pp. 178-179(2)
Authors: Cybal M.M.C.; Druzynska J.; Wojcikowski C.

Improvement of the biocompatibility of microencapsulated islets of langerhans in vivo by using high-molecular-weight alginate (hMw-alginate)
pp. 179-179(1)
Authors: Feilen P.J.; Schneider S.; Slotty V.; Beyer J.

Transgenic tilapia with a ''humanized'' insulin gene: An inexpensive future source of donor islets for clinical islet xenotransplantation
pp. 179-179(1)
Authors: Wright J.R.; Pohajdak B.

Production of bioactive diarginyl-insulin by transplanted genetically engineered human liver cells
pp. 180-180(1)
Authors: Tuch B.E.; Simpson A.M.; Gross D.J.; Holman S.; Yao M.; Tabiin M.T.; Humphrey R.K.B.

Membrane immunoisolation of a diffusion chamber for a bioartificial pancreas
pp. 180-180(1)
Authors: Ohgawara H.; Hirotani S.; Edamura K.; Sasaki S.; Miyazaki J.I.

Tetracycline-regulated secretion of human pro/insulin in transfected primary rat myoblasts
pp. 180-180(1)
Authors: Scougall K.T.; Maltin C.A.; Shaw J.A.M.

Induction of islet tolerance, with co-culture of islets & hepatic cells before transplantation in wistar rats
pp. 180-181(2)
Authors: Soto M.L.; Jara A.; Del Rio R.; Gonzalez G.; Martin-Scapa M.C.

Sequential co-transplantation of hepatic cells and pancreatic islets in wistar rats with long-evans or wistar rats as recipients
pp. 181-181(1)
Authors: Jara A.; Soto M.L.; Del Rio R.; Martin-Scapa M.C.

Comparison of sequential co-transplantation of hepatic cells and islets via porta/porta and cava/porta vein in rats without immunosuppression
pp. 181-181(1)
Authors: Soto M.L.; Jara A.; Del Rio R.; Martin-Scapa M.C.

Oxygen consumption of pancreatic islets and insulin-producing cell lines: A comparative study
pp. 181-182(2)
Authors: Bloch K.; Beer S.; Vardi P.

Chronic complications prevent islet engraftment at three transplantation sites
pp. 182-182(1)
Authors: Moore W.V.; Bieser K.; Geng Z.; Kover K.

CD40/CD154 blockade and islet transplantation in the autoimmune diabetic DRBB rat
pp. 182-182(1)
Authors: Kover K.L.; Geng Z.; Hess D.; Benjamin C.D.; Moore W.V.

Islets isolated from 1- to 3-day-old and 1-month-old pigs have different characteristics and effects on transplantation
pp. 182-183(2)
Authors: Juang J.-H.; Hsu B.R.-S.; Kuo C.-H.; Fu S.-H.; Lee W.-C.; Yao N.-K.

Role of NADH shuttles in insulin secretion in fetal rat -cells
pp. 183-183(1)
Authors: Tan C.; Tu J.; Tuch B.E.; Brown S.A.

Islet allograft rejection is prevented by targeting janus kinase 3 with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131)
pp. 183-183(1)
Authors: Cetkovic-Cvrlje M.; Olson C.M.; Dragt A.L.; Uckun F.M.

Islet allograft survival in signal transducer and activator of transcription factor (STAT)4- and STAT6-deficient mice
pp. 183-183(1)
Authors: Cetkovic-Cvrlje M.; Olson C.M.; Dragt A.L.; Uckun F.M.

Prevention of development of type 1 diabetes in NOD mice by targeting janus kinase (JAK)3 with 4-(4'-hydroxyphenyl)-amino-6,7-dimethoxyquinazoline (WHI-P131)
pp. 184-184(1)
Authors: Cetkovic-Cvrlje M.; Dragt A.L.; Uckun F.M.

Analysis of the metabolic requirements for the creation of immunoresistant cell surrogates
pp. 184-184(1)
Authors: Faradji R.N.; Havari E.; Moriarty M.; Mulligan R.C.; Corkey B.E.; Lipes M.A.

No association of paternal insulin sensitivity with parameters of fetal growth
pp. 184-184(1)
Authors: Jahan S.; Zinnat R.; Chowdhury T.A.; Khatun S.; Khan A.K.A.; Ali L.

Effect of fetal undernutrition on mitochondrial gene expression in rat
pp. 184-184(1)
Authors: Park H.K.; Jeon H.J.; Kim M.S.; KimPak Y.M.; Park K.S.; Lee K.-U.; Kim S.Y.; Kim S.K.; Lee H.K.

Excessive maternal transmission of type 3 diabetes not apparent in the goto kakizaki rat
pp. 185-185(1)
Authors: Adams D.; Gill-Randall R.J.; Housler K.; Alcolado J.C.

The role of the intrauterine environment and low birth weight in the pathogenesis of type 2 diabetes mellitus
pp. 185-185(1)
Authors: Hernandez-Valencia M.; Stein A.; Patti M.-E.

Insulin sensitivity in high altitude and in sea level
pp. 185-185(1)
Authors: Torres J.; Castillo O.; Woolcott O.; Iturrizaga R.; Florentini E.; Damas L.

Insulin-like growth factor-I improves glucose metabolism and hepatic amino acid-N conversion in patients with liver cirrhosis
pp. 185-186(2)
Authors: Grofte T.; Greisen J.; Christiansen J.S.; Vilstrup H.; Schmitz O.

Differences in leptin, insulin sensitivity and insulin clearance in caucasians, Chinese and Asian Indians
pp. 186-186(1)
Authors: S. Liew C.F.; Seah E.S.; Lee K.O.; Wise S.D.

Insulin signal transduction and glucose transport in adipocytes from obese women: Effects of low calorie diet
pp. 186-186(1)
Authors: Bjornholm M.; Al-Khalili L.; Krook A.; Rossner S.; Zierath J.R.; Arner P.

Insulin resistance of human adipose tissue in obesity measured with [¹⁸F]FDG and PET
pp. 186-186(1)
Authors: Virtanen K.A.; Peltoniemi P.; Marjamaki P.; Asola M.; Parkkola R.; Huupponen R.; Lonnroth P.; Ronnemaa T.; Knuuti J.; Nuutila P.

Insulin resistance and high TNF concentrations precede obesity in rats fed high carbohydrate diet during suckling period
pp. 187-187(1)
Authors: Ghanim H.; Srinivisan M.; Aalinkeel R.; Patel M.S.; Dandona P.

Decreased leptin uptake in hypothalamic nuclei with aging in wistar rats
pp. 187-187(1)
Authors: Fernandez C.; Fernandez T.; Campoy F.; Arco A.D.; Arribas C.; Andres A.; Ros M.; Carrascosa J.M.

Changes in plasma leptin concentration and leptin expression in adipose tissue with aging in wistar rats
pp. 187-187(1)
Authors: Campoy F.; Arribas C.; Arco A.D.; Fermin Y.; Perez C.; Andres A.; Ros M.; Carrascosa J.M.

Identification of quantitative trait loci for obesity phenotype by whole-genome scan in the OLETF rat
pp. 188-188(1)
Authors: Ogino T.; Wei S.; Wei K.; Moralejo D.H.; Kose H.; Mizuno A.; Shima K.; Yamada T.; Matsumoto K.

Pitfalls in interpretation of experiments using etomoxir as an inhibitor of CPT I-dependent fatty acid oxidation
pp. 188-188(1)
Authors: Esser V.; Hajibashi S.; Stevenson B.E.; Luiao M.; McGarry J.D.

Is 2-bromopalmitate a valid tool to trace the tissue distribution of circulating fatty acids?
pp. 188-189(2)
Authors: Esser V.; Hajibashi S.; Stevenson B.E.; McGarry J.D.

Reduced membrane transport of long chain fatty acid (LCFA) in the muscle of fat, insulin resistant rats (JCR:LA-cp): A mechanism that may contribute to obesity
pp. 189-189(1)
Authors: Calles J.; Cefalu W.T.; Sweet L.; Russell J.C.

Diet composition, insulin sensitivity and leptin levels in lean and obese mice
pp. 189-189(1)
Authors: Bryson J.M.; Walker C.G.; Phuyal J.L.; Caterson I.D.

The mechanism of long lasting feeding effect of agouti related peptide - an evidence supporting a role for the melanocortin 3 receptor
pp. 189-189(1)
Authors: Kim M.S.; Small C.J.; Abbott C.R.; Rossi M.; Park H.K.; Park K.S.; Lee H.K.; Bloom S.R.

Effect of exercise training on plasma leptin and muscle glycogen and triacylglycerol content in high-fat fed rats
pp. 189-190(2)
Authors: Dzienis-Straczkowska S.; Kowalska I.; Straczkowski M.; Kinalska I.

Islet cell antibodies and insulin autoantibodies in family of first degree of diabetics type 1
pp. 190-190(1)
Authors: Marquez I.; Calderin R.; Gonzalez F.; Buchaca E.; Fernandez F.; Rodriguez L.; Lara E.

Fasting increases insulin-stimulated glucose uptake and activation of PKB
pp. 190-190(1)
Authors: Jebens E.; Jensen J.

The economic burden of diabetes in India: Results from a national survey
pp. 190-190(1)
Authors: Bjork S.; Kapur A.; Sylvest C.; Kumar D.; Kelkar S.; Nair J.

Hospitalization expenditure for diabetes mellitus in Israel
pp. 190-191(2)
Authors: Stern E.; Benbassat C.A.; Najshoni A.; Blum I.

Economic impact of diabetes in Slovakia: Direct costs are closely related to glycemic control
pp. 191-191(1)
Authors: Krahulec B.; Minarik P.; Gudaba M.; Strbova L.; Valasek F.; Janec S.; Papp I.

Direct cost of diabetes in Tunisia
pp. 191-191(1)
Authors: Abid A.; Chabchoub S.; Jamoussi H.; Kamoun H.; Soussi S.; Nagati K.

CODE-2^*: An opportunity to compare costs and management of people with type 2 diabetes in UK and the USA?
pp. 191-192(2)
Author: Williams R.R.

Type 2 diabetes in the UK: Future prevalence and economic burden
pp. 192-192(1)
Authors: Bagust A.; Hopkinson P.K.; Currie C.J.

Cost of antibiotic treatment of diabetic patients in a medical department of a university hospital
pp. 192-192(1)
Authors: Tsapogas P.; Giannikopoulos G.; Tentolouris N.; Mouktaroudi M.; Petrikkos G.; Toskas A.; Katsilambros N.

Communitary intervention in diabetes. Economic impact
pp. 192-192(1)
Authors: Aldana D.; Perich P.; Diaz O.; Dominguez E.; Seuc A.; Diabetes Mellitus Intervention Group

Patients value the clinical characteristics and convenience of Humalog⁽R) mix25&unknown;: Results of a willingness to pay study in patients with type 2 diabetes
pp. 192-193(2)
Authors: Davey P.; Rajan N.; Schultz M.; Chen J.; Croker V.; Aristides M.; Thiebaud D.

Practical activities to improve the insulin supply crisis in countries in urgent need and the activities of Insulin for Life Incorporated (IFL)
pp. 193-193(1)
Author: Raab R.S.

Cost-effectiveness of pioglitazone versus acarbose, metformin, and sulphonylureas in the United Kingdom
pp. 193-193(1)
Authors: Palmer A.J.; Weiss C.; Roze S.; Bumann E.; Foerdoes L.; Brandt A.; Spinas G.A.

Cost-effectiveness of adding either pioglitazone or acarbose to metformin in the United Kingdom
pp. 193-194(2)
Authors: Palmer A.J.; Weiss C.; Roze S.; Bumann E.; Foerdoes L.; Brandt A.; Spinas G.A.

Employment and disability of persons with diabetes mellitus
pp. 194-194(1)
Author: Skerjanc A.

Social-medical and economical aspects of diabetic patients disability
pp. 194-194(1)
Author: Shagazatova B.K.H.

Diabetes management: Patients report on their diabetes care
pp. 194-194(1)
Authors: Ellingson L.K.; Robertson K.E.; Litz T.; Signori M.

Empowerment-based diabetes care for medically underserved persons: Making a difference
pp. 195-195(1)
Authors: Tannas C.L.; Anderson R.M.; Schwartz L.M.

Assessing the framingham risk equations for predicting coronary heart disease in type 2 diabetes
pp. 195-195(1)
Authors: McEwan P.C.; Peters J.; Currie C.J.; Patrick-Hopkinson; Griffiths J.D.; Williams J.E.

A metabolic model of type 2 diabetes
pp. 195-195(1)
Authors: Hummel S.; Bagust A.; Evans M.; Hopkinson P.K.

Diabetes well e-clinic
pp. 196-196(1)
Authors: Prendergast J.; Mayes P.

Developing a computer-based diabetes management system
pp. 196-196(1)
Authors: Weaver T.W.; Upham P.A.; Mazze R.S.; Simonson G.D.

Telemedicine in diabetes footcare: How technology overcomes the problem of distance and isolation
pp. 196-196(1)
Authors: Constantino M.I.; McGill M.; Yue D.K.; Bolton T.

Staged Diabetes Management-decision support (SDM-ds): An internet-based system for clinical decision support
pp. 197-197(1)
Authors: Mazze R.S.; Weaver T.; Upham P.; Simonson G.; Bradley R.; Sundem S.; Kiefer R.; Gordon T.; Wesley D.

Diabetes and hypertension: An evaluation of frequency and quality of care from the DiabCare Hungary database
pp. 197-197(1)
Authors: Tamas G.; Kerenyi Z.; Stella P.; Tabak A.G.; The DiabCare Hungary Group

Quality indicators of diabetes care in Poland
pp. 197-197(1)
Authors: Taton J.; Luzniak P.; Czech A.; Lyholm B.

Qualidiab: A dota initiative to implement a quality-of-care control net in Latin America and the Caribbean
pp. 197-198(2)
Authors: Gagliardino J.J.; Kleinebreil L.; Lapertosa S.; Libman A.; Olivares L.; Rodriguez M.; Sinay I.; Escobar M.C.; Escobar I.D.; Canete F.; Draper R.; de Sanz N.S.

Incidence of diabetes mellitus type 1 in the Varmia and Mazury Region, Poland, in patients aged 0-29, 1994-1999
pp. 198-198(1)
Authors: Bandurska-Stankiewicz E.; Aksamit E.; Zasadowska W.; Wadolowska L.; Trzaskowska A.

Perception of the risk of developing diabetes in the offspring of type 2 diabetic patients
pp. 198-198(1)
Authors: Kim J.T.; Choi S.J.; Kong B.H.; Oh Y.S.; Shinn S.H.

Validation of a point poll as a tool to find impaired glucose tolerance in a representative sample of Mexican women
pp. 198-198(1)
Authors: Carrillo J.L.; Aparicio J.; Reyes M.; Diaz W.; Pena A.; Lazzieri P.; Esqueda G.; Rosales A.

National diabetes prevention and control program in the Mexican Institute of Social Security
pp. 199-199(1)
Authors: Alpizar M.S.; Aceves D.S.; Castro M.A.R.; Madrazo M.N.

Experiences on diabetic ketoacidotic patients - changes for the millennium
pp. 199-199(1)
Authors: Dudas M.; Ivanyi J.

Cardiovascular function in insulin dependent patients
pp. 199-199(1)
Authors: Velasco R.; Gaitan G.; Arellano K.; Giron G.; Donis S.

Camptodactilia in insulin dependent patients with diabetes mellitus
pp. 199-199(1)
Authors: Velasco R.; Sosa J.; Rivera C.; Zuniga E.

The changes of opioid activity in diabetes mellitus type 1
pp. 200-200(1)
Authors: Szewczyk L.; Tarkowska A.; Witkowski D.

The changes of catecholaminergic activity in a course of diabetes mellitus type 1
pp. 200-200(1)
Authors: Szewczyk L.; Lozowska A.; Witkowski D.

Comparison of the musculoskeletal profile in type 1 diabetic patients and subjects control
pp. 200-200(1)
Authors: Mendiola-Anda C.; Gonzalez A.; Morales I.; Rivera A.; Meza M.

Description of an outpatient nutrition group for severely obese innercity adolescents with and without diabetes, including a parent component
pp. 200-201(2)
Authors: Hill J.; Aschliman S.

Sexual dimorphism in the expression of GAD65 autoantibodies at onset of type 1 diabetes in contrasting populations
pp. 201-201(1)
Authors: Korman E.; Stankiewicz W.; Fichna P.; Rewers M.

Acanthosis Nigricans: The education and screening project
pp. 201-201(1)
Author: Villas P.

Acanthosis Nigricans in children: The path to type 2 diabetes & associated health complications
pp. 201-201(1)
Author: Villas P.

Microsatellite allele A5.1 of MHC class I chain related gene A is associated with slow onset autoimmune diabetes in clinical non-insulin dependent diabetes patients in Latvia
pp. 201-202(2)
Authors: Shtauvere-Brameus A.; Berzina L.; Ghaderi M.; Sanjeevi C.B.

Microsatellite allele 5.1 of major histocompatibility complex class I chain related gene A (MIC-A) is increased among non-insulin dependent diabetes mellitus patients from Eastern India
pp. 202-202(1)
Authors: Berzina L.; Shtauvere - Brameus A.; Ghaderi M.; Kanungo A.; Samal K.C.; Sanjeevi C.B.

Alstrom syndrome - the case for secondary prevention
pp. 202-202(1)
Authors: Paisey R.B.; Carey C.M.; Parkinson M.J.; Parkinson C.; Cole M.D.

Diabetic ketoacidosis: A complication of type 2 diabetes in Canadian aboriginal youth
pp. 202-202(1)
Authors: Sellers E.A.C.; Dean H.J.

Diabetes, impaired fasting glucose, and elevated HbA1c in U.S. adolescents: The third National Health and Nutrition Examination Survey
pp. 202-203(2)
Authors: Fagot-Campagna A.; Saaddine J.B.; Flegal K.M.; Beckles G.L.

Space-time clustering at diagnosis in type 1 diabetes in South-East part of Sweden
pp. 203-203(1)
Authors: Samuelsson U.; Carstensen J.; Ludvigsson J.

Serum glucose and insulin in siblings with extreme insulin resistance caused by Ile 119>Met mutation in insulin receptor - seven year follow-up
pp. 203-203(1)
Authors: Siitonen O.; Berg B.; Lestringant G.; Orban T.

HLA class I and II molecules on the surface of lymphomononuclear cells in patients with newly diagnosed type 1 diabetes mellitus
pp. 203-204(2)
Authors: Fernandes A.P.M.; Donadi E.A.; Foss M.C.

Time-trend in the number of diabetic patients by age at onset and type of diabetes in Japanese diagnosed before the age of 30
pp. 204-204(1)
Authors: Uchigata Y.; Otani T.; Okada T.; Miura J.; Okudaira M.; Kobayashi H.; Osawa M.; Yamada H.; Iwamoto Y.

C-peptide and insulin levels; incidence of IAA, anti GAD and anti IA-2 autoantibodies in first degree relatives of diabetic patients and healthy age matched children
pp. 204-204(1)
Authors: Lauk-Puchala B.; Glowacka E.; Zawodniak-Szalapska M.; Szalecki M.; Malagocka E.; Lewkowicz P.; Cypryk K.; Tchorzewski H.

Role of insulin in CD95 fas/apo-1 molecule expression, autoreactive T lymphocyte apoptosis and inflammatory cytokines production in vitro by lymphocytes from patients with high risk type I diabetes mellitus
pp. 204-205(2)
Authors: Glowacka E.; Banasik M.; Tchorzewski H.; Szalapska-Zawodniak M.; Szalecki M.; Lewkowicz P.

Estimates of sensitivity, specificity and positive predictive value of combined antibody analysis for detecting type 1 diabetes in urine glucose screening at school
pp. 205-205(1)
Authors: Urakami T.; Nitadori Y.; Kubota S.; Owada M.; Kitagawa T.

57th amino acids of HLA class II (DR, DQ, DP) chains in Japanese IDDM
pp. 205-205(1)
Authors: Niihira S.; Fujimoto Y.; Yagawa K.; Kimura K.; Nishimaki K.; Kawamura T.; Inada H.; Nabeya N.

Activation of coagulation in children with diabetes mellitus type 1 - evaluation of selected molecular parameters of the hypercoagulability
pp. 205-206(2)
Authors: Teisseyre J.; Piontek E.; Brett-Chrusciel J.; Lukasiewicz H.

Discrepancy between basal insulin level and the poor response to glucose stimulation in Japanese obese adolescents with type 2 diabetes under good glycemic control
pp. 206-206(1)
Authors: Kobayashi K.; Amemiya S.; Mochizuki M.; Kobayashi K.; Ishihara T.; Nakazawa S.

Can published norms be used to assess the prevalence of obesity in children with diabetes?
pp. 206-206(1)
Authors: Witmans M.; Jadavji N.; Lemay J.-F.; Stephure D.; Pacaud D.

Development of type 1 diabetes despite severe hereditary B lymphocyte deficiency: No pathogenic role of B lymphocytes
pp. 206-206(1)
Authors: Martin S.; Kruger D.; Duinkerken G.; Scherbaum W.A.; Kolb H.; Roep B.O.

Increasing prevalence of type 2 diabetes mellitus in children and adolescents in Hungary
pp. 206-207(2)
Authors: Korner A.; Madacsy L.; Tulassay T.

Prevention of IDDM in children with prediabetes using insulin
pp. 207-207(1)
Authors: Kuae A.P.; Piontek E.; Chrusciel J.

Which patient factors trigger a diagnosis of atypical childhood diabetes?
pp. 207-207(1)
Authors: Baumann E.E.; Cashin K.; Chang Y.-T.; Duck S.; Edidin D.; Lipton R.B.

The insulin gene region contributes to IDDM susceptibility independently of HLA class II genes in Polish diabetic patients
pp. 207-207(1)
Authors: Krokowski M.; Bodalski J.; Beaurain G.; Machejko P.; Abel M.; Caillat-Zucman S.; Garchon H.-J.

Disturbances of the carbohydrate metabolism in children with lymphoblastic leucemia. Preliminary informations
pp. 207-208(2)
Authors: Iwanicka Z.; Wasikowa R.B.; Pisarek J.; Weclawek-Pepol J.; Basiak A.A.B.

Population-based screening for pre-diabetes in children may be conceived as reassuring
pp. 208-208(1)
Authors: Ludvigsson M.; Sepa A.; Ludvigsson J.

Is diabetes protective against asthma in children?
pp. 208-208(1)
Authors: Grover V.; Keenan H.; Walsh M.G.; Deiravi K.E.; Onyemere K.; Alva E.; Lipton R.B.

Neonatal diabetes. Transitory or permanent?
pp. 208-208(1)
Authors: Ramos O.; Taberner P.; Ferraro M.C.; de Cabo C.

Remission phase of type 1 diabetes in children in the Republic of Macedonia
pp. 209-209(1)
Authors: Kocova M.J.; Sukarova-Angelova E.P.; Krstevska-Konstantinova M.M.

A case of alstrom syndrome with insulin resistance, diabetes, hyperandrogenemia and hepatic dysfunction
pp. 209-209(1)
Authors: Jungheim K.; Huebinger A.

Incidence of type 1 diabetes mellitus in children and young adults in a Province of Austria, 1994 - 1996
pp. 209-210(2)
Authors: Rami B.; Waldhoer T.; Schober E.

Prevalence of type 2 diabetes and impaired glucose tolerance in obese Argentine children
pp. 210-210(1)
Authors: Ozuna B.A.; Araujo M.B.; Krochik A.G.; Mazza C.S.

Breastfeeding and type 1 diabetes mellitus
pp. 210-210(1)
Authors: Barriocanal L.A.; Benitez G.; Benitez S.; Alvarez M.; Canete F.

Incidence of type 1 diabetes mellitus in Romania in the age group 0-14 years
pp. 210-210(1)
Authors: Ionescu-Tirgoviste C.; Guja C.; Calin A.; Mota M.

Feasibility of diabtel use in the follow-up of type 1 diabetic patients
pp. 210-211(2)
Authors: Cermeno J.; Corcoy R.; Brugues E.; Hernando E.; Gomez E.; de Leiva A.

Insulin pumps on pediatric patients: The Mayo clinic experience
pp. 211-211(1)
Authors: Minutti C.Z.; Thurlow B.K.; Zimmerman D.

Gestational diabetes: Systematic screening and follow up in a population of 900 women
pp. 211-211(1)
Authors: Huet D.; Sert C.; Luna N.; Hautecouverture M.

What advice is given to women with type I diabetes regarding contraception?
pp. 211-211(1)
Authors: Connor S.; Clegg C.; Ollerton I.; Casson I.F.; Kidd K.; Kidd G.M.

Diabetic pregnancy-outcome and trends, 10 year prospective study
pp. 211-212(2)
Authors: Casson I.F.; Platt M.J.; Stanisstreet M.; Howard C.V.; Walkinshaw S.A.; Pennycook S.; Mckendrick O.; Stott A.

Maternal mortality in 972 women with IDDM between 1975 and 1998
pp. 212-212(1)
Authors: Teramo K.; Hiilesmaa V.; Leinonen P.

Glycemic control in early pregnancy influences the risk of pre-enclampsia in women with type I diabetes mellitus
pp. 212-212(1)
Authors: Teramo K.; Suhonen L.; Hiilesmaa V.

Gestational diabetes mellitus: Do we need to revise the standard criteria for diagnosis?
pp. 212-213(2)
Author: Gupta S.

Microalbuminuria in pregnancies with type 1 diabetes
pp. 213-213(1)
Authors: Topolska J.; Kinalski M.; Zarzycka B.; Zarzycki W.; Abdelrazek S.S.; Kinalska I.

Efficacy of world health organization (WHO) recommended glucose tolerance test (75-g GTT) in pregnancy
pp. 213-213(1)
Authors: Al-Arfaj A.A.; Al-Aithan A.A.; Hassounah M.M.; Al-Jaser S.J.; Al-Sultan S.S.

Education and insulin adjustment in pregnant women in an out-patient method in Iran
pp. 213-213(1)
Authors: Nikousokhan A.K.; Rajab A.; Parsian N.; Eftekharzadeh A.

PGE₂ production and ³H-PGE₂ transport in diabetic rat embryos and in rat embryos cultured in the presence of diabetic serum
pp. 214-214(1)
Authors: Jawerbaum A.; Gonzalez E.; Sinner D.; Pustovrh C.; White V.; Gimeno M.

The effects of HCl-Ritodrine on the metabolism of carbohydrates and fats in pregnant women with impaired glucose tolerance
pp. 214-214(1)
Authors: Bikas N.; Bikas A.; Hall A.

Twenty years of management of diabetic pregnancy what was achieved? What must be improved?
pp. 214-214(1)
Authors: Blouza S.C.; Miri I.; Kamoun H.J.; Abid A.; Hamdi W.; Nagati K.

Metabolic control in women with type 1 diabetes during and after pregnancy
pp. 214-215(2)
Authors: Asatiani N.; Kurashvili R.; Natsvlishvili M.; Dundua M.; Shelestova L.; Chanturia T.; Ramazashvili M.; Hod M.; Itameri H.

Thickness of subcutaneous fat tissue where pregnant diabetics inject their insulin - an ultrasound study
pp. 215-215(1)
Authors: Engstrom L.; Jinnerot H.; Jonasson E.

Case presentation: An unusual cause of severe peripartum hypoglycaemia in type I diabetes
pp. 215-215(1)
Authors: Hassanein M.M.; Ewins D.L.; Worth R.C.

Results of improved care for pregnant diabetic women in years 1970 - 1999 in a district of Slovakia
pp. 215-215(1)
Authors: Korecova M.; Tarina F.; Chovanec M.; Chlapecka J.; Vicianova V.

St Vincent declaration on diabetic pregnancies: How far are we?
pp. 215-216(2)
Authors: Bhattacharyya A.; Brown S.; Hughes S.M.; Vice P.A.

Can intensive management with a team approach prevent complications of diabetic pregnancies with delayed referral?
pp. 216-216(1)
Authors: Ossar Z.; Madazh R.; Devranoglu G.; Sipahi S.; Damci T.; Yumuk V.; Ozyazar M.; Ilkova H.

Is there an increased risk for infants of mothers with one abnormal value in 100gr OGTT?
pp. 216-216(1)
Authors: Osar Z.; Madazli R.; Damci T.; Yumuk V.; Ozyazar M.; Ilkova H.

Insulin lispro in pregnancy
pp. 216-216(1)
Authors: Bandurska-Stankiewicz E.; Zasadowska W.

Outcomes of Pregnancy in women with type I diabetes mellitus in planning and non-planning groups
pp. 217-217(1)
Authors: Razna I.; Czech A.; Taton J.

Gender differences in the adjustment to diabetes type 1: The role of coping, depression and marital relation
pp. 217-217(1)
Authors: Enzlin P.; Mathieu C.H.; Demyttenaere K.

Patient education: A crucial factor in well-being of type 2 diabetic patients
pp. 217-218(2)
Authors: Topsever P.; Salman S.; Aydin N.; Sengul A.M.; Aran S.N.; Sipahioglu F.; Yilmaz T.M.; Satman I.

What is the most important predictor of metabolic control, belief in yourself or belief in your treatments effectiveness?
pp. 218-218(1)
Authors: Howells L.A.L.; Skinner T.C.; Greene S.A.; Wilson A.; Newton R.

General knowledge, quality of life, anxiety and depression in type 1 and type 2 diabetes mellitus previous to any educational intervention
pp. 218-218(1)
Authors: Matteucci E.; Conversano C.; Piazza F.; Calvi D.; Marchini F.; Giampietro O.

The impact of improved glycemic control on quality of life in patients with diabetes: Does socioeconomic status play a role?
pp. 218-219(2)
Authors: Zgibor J.C.; Wesche J.; Gallagher N.; Kaufman S.T.; Korytkowski M.T.; Rao H.

Use of insulin lispro (Humalog⁽R)) mixtures in the elderly provides comparable safety to that of human insulin mixtures
pp. 219-219(1)
Authors: Malone J.K.; Arora V.K.; Bue-Valleskey J.M.

Humalog⁽R) mix25&unknown; twice daily versus glibenclamide improves glycemic control in patients with type 2 diabetes
pp. 219-219(1)
Authors: Roach P.; Koledova E.; Wyatt J.; Shoustov S.B.; Antsiferov M.B.; Melnichenko G.A.

Oral insulin metformin combination therapy for treatment of type - 2 diabetes
pp. 219-220(2)
Authors: Lewin A.; Modi P.

Effect of metformin/glyburide tablets on postprandial insulin as first-line in type 2 diabetes
pp. 220-220(1)
Authors: Piper B.A.; Rosenstock J.; Donovan D.

The evaluation of the efficacy, safety and tolerability of glimepiride in patients with type 2 diabetes
pp. 220-220(1)
Authors: Karnafel W.; Jasik M.; Drzewoski J.; Kasperska-Czyzyk T.; Lopatynski J.

Improved glucose control following administration of a 75% insulin lispro/25% NPL mixture in patients with type 1 diabetes
pp. 220-221(2)
Authors: Pein M.; Deibler J.; Roach P.; Woodworth J.; Gudat U.; Dryer M.

Use of insulin lispro (Humalog⁽R)) with CSII provides consistently better glycemic control than regular human insulin
pp. 221-221(1)
Authors: Bue-Valleskey J.M.; Beattie S.D.; Frisby D.S.; Babbey L.E.; Malone J.K.

CSII vs. conventional therapy at onset of type 1 diabetes: The IMDIAB VIII randomized trial
pp. 221-221(1)
Authors: Paolo P.; IMDIAB Group

Long term intensive insulin treatment in type 1 diabetic patients: Effect on HbA_1c, body weight, serum lipids and renal function
pp. 221-221(1)
Authors: Fovenyi J.; Thaisz E.; Lehotkai L.; Grosz A.; Sallai T.; Kocsis G.

The short- and long-lasting effect of metformin in type I diabetic patients
pp. 221-222(2)
Authors: Lacigova S.; Rusavy Z.; Jankovec Z.; Zolkova P.; Karova R.; Cechurova D.

Changes in arterial blood pressure during a postural test in type 2 diabetic patients treated by ACE inhibitors or beta-blockers
pp. 222-222(1)
Authors: Estrella F.R.; Marchand M.M.; Lefebvre P.J.; Scheen A.

Spectral analysis of blood pressure variability in type 1 diabetic patients with polyneuropathy
pp. 222-222(1)
Authors: Lengyel C.; Legrady P.; Torok T.; Varkonyi T.T.; Gingl Z.; Abraham G.; Kempler P.; Rudas L.; Lonovics J.

Are hypertensive type 2 diabetic patients properly treated?
pp. 222-223(2)
Authors: Hommel E.; Schepler M.; Vibe-Petersen J.; Jorgensen T.; Perrild H.

High prevalence of hypertension and insufficient blood pressure control among Argentinian with type 2 diabetes
pp. 223-223(1)
Authors: Taverna M.J.; Ruiz J.; Frechtel G.; Ruiz M.

Sphygmomanometrically determined pulse pressure is a component of insulin resistance syndrome
pp. 223-223(1)
Authors: Kazumi T.; Kawaguchi A.; Hirano T.; Yoshino G.

Efficacy and safety of insulin aspart compared to buffered human insulin by continuous SC insulin infusion
pp. 223-224(2)
Authors: Bode B.; Strange P.; McCulloch K.

Autohemotherapy effects on the treatment of diabetes mellitus type 2
pp. 224-224(1)
Author: Gonzalez-Ramirez J.

Chronic effect of pterospermum acerifolium bark on glycemic and lipidemic status of type 2 diabetic model rats
pp. 224-224(1)
Authors: Murshed S.; Rokeya B.; Ali L.; Nahar N.; Khan A.K.A.; Mosihuzzaman M.

The improvement of insulin resistance by using growth hormone reduces the risks of atherosclerosis in obese diabetic patients
pp. 224-224(1)
Authors: Nam J.-H.; Huh K.-B.; Lee H.-C.; Song Y.-D.; Kim K.-R.; Lim S.-K.

Comparative studies of impaired glucose tolerance in dogs treated with S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine
pp. 224-225(2)
Authors: McGrowder D.; Ragoobirsingh D.; Dasgupta T.

Functional analysis of mutations in PDX1 found in patients with type II diabetes
pp. 225-225(1)
Authors: Campbell S.C.; Shepherd L.; Groop L.; Hattersley A.T.; Macfarlane W.M.

Glucose intolerance in human IAPP transgenic mice on high-fat diet is independent of islet amyloid
pp. 225-225(1)
Authors: Ahren B.; Oosterwijk C.; Nieuwenhuis M.G.; Thijssen J.H.H.; Lips C.J.M.; Hoppener J.W.M.

Protective effect of the pro12Ala variant of the human peroxisome proliferator activated receptor 2 on obesity, insulin sensitivity and glucose tolerance
pp. 225-226(2)
Authors: Temelkova-Kurktschiev T.S.; Laakso M.; Leonhardt W.; Hanefeld M.

Obese IRS-1(+/-) mice as a model for type 2 diabetes
pp. 226-226(1)
Authors: Shirakami A.; Araki E.; Toyonaga T.; Motoshima H.; Yoshizato K.; Kawashima J.; Kishikawa H.; Kahn C.R.; Shichiri M.

Gly1057Asp allelic variant of IRS-2 gene has synergistic effect with Gly972Arg variant of IRS-1 on insulin secretion in obesity and NIDDM
pp. 226-226(1)
Authors: Grigorescu F.; Lautier C.; Mkadem S.A.E.; Macari F.; Brun J.-F.; Gris J.-C.; Guttierez J.; Cros G.; Mercier J.; Bringer J.; Jaffiol C.

Mortality in a whole-country cohort of childhood onset (0-18 years) diabetic patients in Israel
pp. 226-226(1)
Authors: Laron Z.; Laron-Kenet T.; Shamis I.; Rosen S.; Weitzman S.

Severe hypoglycemia in 7940 children and adolescents with type-1 diabetes mellitus treated at 74 German Pediatric Diabetes Centers
pp. 227-227(1)
Authors: Holl R.W.; Grabert M.; Schwab O.; Schweigger F.

Eating disturbances among girls with type 1 diabetes mellitus (DM): Examining the role of family dysfunction and mother's eating and weight control behaviors as contributing risk factors
pp. 227-227(1)
Authors: Maharaj S.I.; Rodin G.M.; Connolly J.A.; Olmsted M.P.; Daneman D.

Transforming growth factor-1 expression is stimulated less in the kidney of prepubertal than mature rats with diabetes
pp. 227-227(1)
Authors: Lane P.H.; Snelling D.M.; Hollman A.; Langer W.J.

Effects of diabetes on learning in children
pp. 229-229(1)
Authors: McCarthy A.M.; Lindgren S.; Mengeling M.; Tsalikian E.

Evaluation of the caring process in diabetes mellitus related to the concepts of adherence and quality of live
pp. 229-229(1)
Authors: Velasco M.; Jesus M.; Garcia M.; Manuel J.

Self-efficacy and interrelation of family environment, and metabolic control in adolescents with type one diabetes
pp. 230-230(1)
Authors: Pinar R.; Arslanoglu I.; Issever H.; Cizmeci F.; Isguven P.; Gunoz H.; Yilmaz S.

In which degree is HbA1c an indicator for the patients quality of life?
pp. 230-230(1)
Authors: Iversen M.M.; Hanestad B.R.; Graue M.

Using client priorities to assess quality of life
pp. 230-230(1)
Authors: Griffiths R.D.; Jayasuriya R.; Maitland H.; Thomas H.

Reliability and validity of Turkish version of quality of life well being and treatment satisfaction questionnaires
pp. 230-231(2)
Authors: Sengul A.M.; Sargin M.; Salman F.; Ozer E.; Salman S.; Gedik S.; Karsidag K.; Dinccag N.; Satman I.; Yilmaz M.T.

Locus of health control beliefs in diabetic and healthy children
pp. 231-231(1)
Authors: Prasek M.; Pavlic J.; Pibernik M.; Metelko Z.

Diabetes related worry may be suppressed by natural disasters: Effect of earthquake
pp. 231-231(1)
Authors: Salman S.; Sengul A.; Salman F.; Ozer E.; Gursoy N.; Hatun S.; Karsidag K.; Satman I.; Yilmaz M.T.

Coping among adults with type I and type II diabetes
pp. 231-231(1)
Authors: Karlsen B.; Bru E.

Interaction between perceived barriers and personal model beliefs in predicting dietary self-care
pp. 231-232(2)
Authors: Skinner T.C.; Hampson S.E.

Analysis of psychological factors associated with wholesome behaviors in diabetic patients
pp. 232-232(1)
Authors: Nowakowska J.; Kawalec E.; Sieradzki J.

Psychological support group for diabetic patients as a form of diabetological education. The summary a four-years intervention
pp. 232-232(1)
Authors: Nowakowska J.; Sieradzki J.

Social support and well-being in type 2 diabetes
pp. 232-233(2)
Authors: Kosuri M.; Gumpeny S.R.; Sriram a.

Gender differences in living with type 2 diabetes
pp. 233-233(1)
Authors: Kosuri M.; Gumpeny S.R.; Sriram V.

Prediction of adjustment and control in youth with type 1 diabetes
pp. 233-233(1)
Authors: Lernmark B.M.; Thernlund G.M.; Fredin K.; Hagglof B.

Gender differences in well-being among persons with diabetes in India
pp. 233-233(1)
Authors: Gumpeny S.R.; Kosuri M.; Sriram V.

The impact of the health educational process in the diabetes control in adolecents
pp. 233-233(1)
Author: Oliveira O.

Uncooperative behaviors to medical treatments in diabetic patients analyzed with relationship between patients and nurses
pp. 234-234(1)
Authors: Takahama K.; Fukuyama A.; Furuguchi M.; Fukuyama M.; Fujita J.; Senba M.; Mori Y.

Eating disorder and diabetes mellitus
pp. 234-234(1)
Author: William-Olson L.

Writing in the sand and other methods requiring more creativity than resources
pp. 234-234(1)
Authors: Osler C.E.; Kalk J.W.

Yoga practice in people with diabetes
pp. 234-235(2)
Authors: Mercuri N.; Olivera E.M.; Souto A.; Guidi M.L.; Gagliardino J.J.

Predictors of success in insulin pump therapy
pp. 235-235(1)
Authors: Scherwinski M.; Freund A.M.; Reinhold M.; Austenat E.

Strutured treatment and teaching programmes in elderly patients with type 2 diabetes mellitus: Should they performed pre or after improvement of metabolic control?
pp. 235-235(1)
Authors: Braun A.; Schiel R.; Leppert K.; Muller U.A.

Effect of sildenafil treatment on well-being of diabetic and nondiabetic men with erectile dysfunction
pp. 235-235(1)
Authors: Oblak C.; Ravnik-Oblak M.; Arneric N.

Quality of life in diabetic, otherwise III and healthy persons
pp. 235-236(2)
Authors: Pibernik-Okanovic M.; Szabo S.; Metelko Z.

The effect of a long term structured diabetes education in type 2 diabetes
pp. 236-236(1)
Authors: Li W.; Wang H.

Diabetes Mellitus(DM): The psychosocial impact of its diagnosis on adult Cystic Fibrosis (CF) patients
pp. 236-236(1)
Authors: Connor S.; Cowperthwaite C.; Clegg C.; Casson I.; Walshaw M.

Factitious hypoglycaemia due to surreptitious administration of insulin and oral hypoglycaemic drugs abuse
pp. 236-237(2)
Authors: Ravnik-Oblak M.; Koselj M.

Contradictory reviews of experts to assess drunkenness and/or hypoglycaemia in a type 1 diabetic driver
pp. 237-237(1)
Authors: Chlup R.; Neoral L.

Effects of serotonergic anxiolytic agent, tandospirone, on the ability of self-management in diabetics
pp. 237-237(1)
Authors: Nunol K.; Nakamura U.; Fukui T.; Satho Y.

Diabetics attitudes to recommended nutritional changes
pp. 237-237(1)
Authors: Pavcic M.; Lavrinc J.; Zanoskar M.; Zorko V.

Education and diabetes
pp. 237-238(2)
Author: Vera M.G.

Remission of sins
pp. 238-238(1)
Authors: Nilsson K.; Rylander E.; Karlen M.; Falk L.L.; Berger B.

Diabetes Nutrition and Complications Trial (DNCT): Changes in nutritional pattern and diabetes control in diabetic subjects between 1993 and 1999
pp. 238-238(1)
Author: The Diabetes and Nutrition Study Group of the Spanish Diabetes Association

How well are individuals on intensive insulin therapy counting carbohydrates?
pp. 238-239(2)
Authors: Graff M.R.; Gross T.M.; Juth S.E.; Charlson J.

Implementation of nutritional knowledge by diabetic patients at Pelonomi Hospital, Bloemfontein
pp. 239-239(1)
Authors: Badenhorst A.M.; Dannhauser A.; Vonkeman L.; Oosthuizen L.; Joubert G.

Low-glycaemic index foods mitigates the afternoon glycaemic fall in type 2 diabetic patients
pp. 239-239(1)
Author: Cantagallo A.

The planning, implementation and evaluation of a self study educational program for patients with type I and type II diabetes mellitus
pp. 239-239(1)
Authors: Bodenhorst A.M.; de Wet I.J.

Learning good eating habits playing computer games at school: A 2000 children evaluation
pp. 239-239(1)
Authors: Turnin M.C.; Couvaras O.; Jouret B.; Tauber M.T.; Bolzonella C.; Fabre D.; Tauber J.P.; Hanaire-Broutin H.

Obesity and risk factors of cardiovascular diseases in type II (non-insulin-dependent) diabetes mellitus
pp. 240-240(1)
Authors: Anesto J.B.; Suarez M.M.S.; Suarez A.R.; Hernandez D.G.; Faxas E.B.; Del Valle Z.G.

Evaluation of the dietetic indicators of patients with type II (non-insulin-dependent) diabetes mellitus
pp. 240-240(1)
Authors: Suarez M.M.S.; Anesto J.B.; Suarez A.R.; Hernandez D.G.; Fernandez F.; Bouza R.C.; Lara E.

Dietary habits and its relation to changes in body weight
pp. 240-240(1)
Authors: Kofinis A.J.; Thanopoulou A.C.; Noutsou M.M.; Tountas C.D.; Roussi-Penesi D.P.; Karamanos B.G.

Diabetes and cardiovascular intervention trials in Australia (DACIT)
pp. 240-240(1)
Authors: Gilliland A.; Burton K.

Nutrient intake and antioxidant vitamin level with periodontal disease in NIDDM
pp. 241-241(1)
Authors: Choudhury A.R.; Jahan K.; Banik N.G.; Khan A.K.A.

Wine influence in risk factors and clinical manifestations of coronary heart disease
pp. 241-241(1)
Authors: Rossell R.; Felip A.; Torras R.; Molina A.; Muniz F.

The comparison of recognition between medical remedies and home remedies: In the case of Japanese adults with type 2 diabetes mellitus
pp. 241-241(1)
Authors: Oda K.; Ito M.; Mori Y.

Utilization of health foods and drinks by Japanese diabetic patients
pp. 241-242(2)
Authors: Mori Y.; Ito M.; Oda K.

Long - term effects of dietary protein restriction and the ACE-inhibitors on the microalbuminuria in normotensive IDDM patients
pp. 242-242(1)
Authors: Petkova M.K.; Vutova G.M.

Effect of a modified local bread on blood glucose and lipid levels in diabetic patients
pp. 242-242(1)
Authors: Nahar Q.; Rokeya B.; Mahmood A.K.; Rahman M.; Ali L.

Effects of rice germ oil on lipid metabolism and lipid peroxide formation in streptozotocin-induced diabetic rats
pp. 242-242(1)
Authors: Lee S.; Hwangbo Y.; Chung K.; Kuk S.; Lee Y.

A trial for determination of exercise intensity by means of a simple lactate analyzer
pp. 242-243(2)
Authors: Fujinuma H.; Hoshino T.; Yoshida S.; Seino H.; Abe R.

Clinical trial of plantstanol-ester induced cholesterol-lowering in NIDDM-patients
pp. 243-243(1)
Authors: Vleuten P.V.D.; Bouter K.

Correlation between nourishment habits and abdominal obesity
pp. 243-243(1)
Authors: Dinca M.E.A.; Georgescu F.E.M.

Prevention of diabetic cardiovascular risk by a new -linolenic (ALA) acid-rich diet procedure
pp. 243-243(1)
Authors: Schmitt B.; Weill P.; Legrand P.H.; Chesneau G.; Daniel N.; Safraou M.F.; Corbin G.

Effects of low-protein diet on the pancreatic endocrine function of newborn and adult rats
pp. 244-244(1)
Authors: Doi K.; Yoshida M.

Prevention of nocturnal hypoglycemia in adults with type 1 diabetes: Impact of bedtime snack composition
pp. 244-244(1)
Authors: Kalergis M.; Schiffrin A.; Gougeon R.; Jones P.J.H.; Yale J.-F.

Effects of VLCD therapy on lipid metabolism in obesity
pp. 244-244(1)
Authors: Murase Y.; Yagi K.; Asano A.; Katsuta Y.; Kitatani M.; Koizumi J.; Mabuchi H.

An electric patient record system for diabetes covered with dietary education report by a voice recognition software
pp. 244-245(2)
Authors: Koga T.; Sakabe N.; Tamechika Y.; Matuoka K.

From obesity to diabetes - a multimedia simulation guide
pp. 245-245(1)
Authors: Svacina S.; Kofranek J.

Characteristics of nutritional behavior in diabetic patients: An epidemiological view from the French Monica nutritional survey
pp. 245-245(1)
Authors: Gourdy P.; Ruidavets J.B.; Turnin M.C.; Ferrieres J.; Arveiler D.; Amouyel P.; Simon C.; Marecaux N.; Bingham A.; Ducimetiere P.; Hanaire-Broutin H.

The relationship between nutritional status and glyceamic status of urbanised black subjects previously identified as glucose intolerant
pp. 245-245(1)
Authors: Badenhorst A.M.; Slabber M.; Nel M.; Mollentze W.F.

Combination patterns of medical remedies and home remedies for adults with type 2 diabetes mellitus
pp. 245-246(2)
Authors: Ito M.; Mori Y.; Oda K.

Chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle glut-4 translocation in obese, hyperinsulinemic rats
pp. 246-246(1)
Authors: Wang Z.Q.; Zhang X.H.; Baldor L.C.; Russell J.C.; Cefalu W.T.

Validation of a point poll as a tool to find impaired glucose tolerance in a representative sample of Mexican men
pp. 246-246(1)
Authors: Carrillo J.; Aparicio J.; Reyes M.; Diaz W.; Pena A.; Lazzeri P.; Esqueda G.; Rosales A.

DAYLY insulins necessity during camp vacations and a support group
pp. 246-247(2)
Authors: Oliveira R.B.C.; Figueiredo S.; Rego B.; Correa^de Oliveira R.J R.F.

A book of brief advice in diabetes
pp. 247-247(1)
Authors: Romero J.H.; Iliovich E.; Szymula C.

Thyroxine supplement in patients with hypothyroidism is associated with a reduced prevalence of retinopathy in type 2 diabetes
pp. 247-247(1)
Authors: Sailesh S.; Philip S.; Panja S.; Randeva H.; Hillhouse E.; Hare J.P.; Patel V.

Apolipoprotein(a) phenotype and retinopathy in diabetic patients
pp. 247-247(1)
Authors: Suzuki T.; Okazaki K.; Nakano H.; Oba K.

A generalized computer expert system for diagnosing early lesions of diabetic retinopathy
pp. 247-248(2)
Authors: Lee E.T.; Lee S.C.; Miki E.; Wang Y.; Keen H.

Prevalence of eye diseases and its relationship with diabetes in an American Indian population - the vision Keepers study
pp. 248-248(1)
Authors: Lee E.T.; Russell D.J.; Warn A.; Klein R.; Tolbert B.

Computer time series analysis of early lesions of diabetic retinopathy
pp. 248-249(2)
Authors: Lee S.C.; Lee E.T.; Miki E.; Wang Y.; Keen H.

Variation analysis of computer-assisted diagnosis of fudus images
pp. 249-249(1)
Authors: Lee S.C.; Wang Y.

Higher normal baseline albumin excretion rate (AER) values and diabetic retinopathy are Predictors of future development of diabetic nephropathy in type 2 diabetic patients (DM2)
pp. 249-249(1)
Authors: Murussi M.; Baglio P.; Gross J.L.; Silveiro S.P.

Computer-prompted quantitative human evaluation in early questionable diabetic retinopathy
pp. 249-250(2)
Authors: Miki E.; Keen H.; Wang Y.; Lee S.C.; Lee E.T.

Diabetic population in ophtalmological reference centers
pp. 250-250(1)
Author: Marcantonio R.L.

Ocular complications of diabetes in an afro-Caribbean population: The Barbados eye study
pp. 250-250(1)
Authors: Hennis A.; Wu S.-Y.; Nemesure B.; Li X.; Hyman L.; Leske C.; BES Group

Age at diagnosis, glycaemic control and the development of retinopathy; a population-based cohort study in type 1 diabetic subjects in Canterbury, New Zealand
pp. 250-250(1)
Authors: Florkowski C.M.; Scott R.S.; Coope P.A.; Graham P.J.; Moir C.L.

Use of optical coherence tomography (OCT) in the diagnostic of macular edema in diabetic patients
pp. 250-251(2)
Authors: Moreira R.O.; Trujilho F.; Mufarrej I.C.F.; Ellinger V.C.M.; Zagury L.

Preliminary study on the frequency and degree of diabetic retinopathy among a hospital population
pp. 251-251(1)
Authors: Stolarza Z.Z.S.; Valli H.H.V.; Szuster J.J.S.; Lerner M.M.L.; Marcello S.S.M.; Del Hoyo N.N.D.H.; Gonzalez C.C.G.; Benavides B.B.B.; Dibenedetto A.A.D.; Gossn E.E.G.; Pagnotta L.L.P.

Improve of diabetic rethinopathy screening by using digital retinal camera. Pilot project ministerio de Salud(Minsal) - servicio de Salud Talcahuano(SST), Chile
pp. 251-251(1)
Authors: Bello F.A.; Blanco R.; Munoz E.; Muller G.; Maragano R.; Fanjul S.; Meneses O.; Pinilla M.

Are drusen markers of impaired glucose tolerance?
pp. 251-252(2)
Authors: Manco M.; Mingrone G.; Miccheli A.; De Gaetano A.; Rosa R.; Pescosolido N.; Greco A.V.

Diabetic retinopathy and its risk factors among ambulatory cohort of diabetic type 1
pp. 252-252(1)
Authors: Luzniak P.; Czech A.; Taton J.

Effect of panretinal photocoagulation on retinal hemodynamics in patients with diabetic retinopathy
pp. 252-252(1)
Authors: Okano T.; Osako M.; Matsuno K.; Sugano H.; Ochiai J.

Prevalence of retinopathy in a selected South Indian population in the Chennai Urban Population Study (CUPS)
pp. 252-252(1)
Authors: Rema M.; Shanthirani C.S.; Deepa R.; Mohan V.

Familial clustering of diabetic retinopathy in type 2 diabetic patients
pp. 252-252(1)
Authors: Rema M.; Saravanan G.; Deepa R.; Mohan V.

Retinal perfusion pressure as a predictor in the progression of diabetic retinopathy to sight threatening retinopathy
pp. 253-253(1)
Authors: Patel V.; Sailesh S.; Panja S.; Kohner E.M.

Screening and follow-up of diabetic retinopathy by a new mosaic 9-field fundus photography system
pp. 253-253(1)
Authors: Shiba T.; Yamamoto T.; Sekihara H.; Hagura R.

Lipoprotein (a) in type 1 diabetics: Relation to retinopathy
pp. 253-253(1)
Authors: El-Bahrawi M.A.; Badr M.; Mohy S.E.-D.; Shaarawy A.

Risk factors considered responsible for the development of microangiopathy in NIDDM
pp. 253-254(2)
Authors: Ljubic S.; Brkljacic B.; Pavlic-Renar I.; Metelko Z.

Angiotensin-II type 1 receptor gene polymorphism and diabetic nephropathy in Korean type 2 diabetic patients
pp. 254-254(1)
Authors: Chung M.-Y.; Chung D.-J.; Lee D.-H.; Park J.-T.

Relationship between hypertension and proteinuria in patients with diabetic nephropathy
pp. 254-254(1)
Authors: Tichy B.; Abraham G.; Mohacsi G.; Letoha A.; Legrady P.; Hodi M.; Sonkodi S.

Effect of trandolapril on microalbuminuria and left ventricular mass in normotensive type 1 diabetics - a 1 year follow up
pp. 254-254(1)
Authors: Jasik M.; Karnafel W.; Stawicki S.

Biochemical markers in the evaluation of renal function in diabetes mellitus type 2
pp. 255-255(1)
Authors: Flores-Alfaro E.; Parra-Rojas I.; Roldan-Lopez M.A.; Piza-Roman L.F.; Alarcon-Herrera G.

Chronic Hemodialysis (CHD) in diabetic patients with Chronic Renal Failure (CRF) in Chile. Prospective study. Inicial report
pp. 255-255(1)
Authors: Bello F.A.; Bello M.F.; Parra C.; Rocha M.; Villagran G.

Microalbuminuria detection with micral-test II urine dipstick N in patients with type 2 diabetes mellitus
pp. 255-255(1)
Authors: Pappas S.I.; Sotiropoulos A.; Vlachopoulos V.; Bousboulas S.; Apostolou O.; Skliros E.; Kotsini V.; Tountas C.

The circadian atrial natriuretic peptide and albuminuric responses to volume expansion induced by water immersion
pp. 256-256(1)
Authors: Evans P.M.S.; Goenka N.; Penney M.; O'Hare P.

High sensitive measurement of interleukin-6 (IL-6) in patients with diabetic mellitus
pp. 256-256(1)
Authors: Shikano M.; Kushimoto H.; Hasegawa M.; Murakami K.; Tomita M.; Hasegawa H.; Toba T.

Low creatinine clearance compaired to microalbuminuria as predictive factor for presence of early nephropathy in type II diabetes in India
pp. 256-256(1)
Author: Shah J.M.

Clinical implications of urinary type 4 collagen in diabetic patients with and without nephropathy
pp. 256-257(2)
Authors: Yazawa M.; Minagawa S.; Tsuchida A.; Ohmura E.; Imai Y.; Matsuzaki F.; Kawazu S.; Ichida M.; Horie H.

Prevalence of symptomes of the metabolic syndrome in kidney transplant recipients
pp. 257-257(1)
Authors: Gero L.; Foldes K.; Barna I.; Remport A.; Maklary E.; Jaray J.; Perner F.; deChatel R.

Rosiglitazone added to a sulphonylurea: Effective and well tolerated in patients with type 2 diabetes and mild to moderate renal impairment
pp. 257-257(1)
Authors: Agrawal A.; Jones N.P.; Sautter M.C.

Alterations of glomerular levels of glutathione peroxidase in diabetic nephropathy
pp. 257-257(1)
Authors: Chen H.-C.; Guh J.-Y.; Shin S.-J.; Lai Y.-H.

Diabetic nephropathy is associated with the Z-2 microsatellite allele of the aldose reductase gene in chinese subjects with type 2 diabetes
pp. 257-258(2)
Authors: Liu Y.F.; Wat N.M.S.; Chung S.S.M.; Lam K.S.L.

Is microalbuminuria associated to other features of metabolic syndrome in Japaneses?
pp. 258-258(1)
Authors: Ferreira S.R.G.; Gimeno S.G.A.; Rosenbaum P.; Franco L.J.; Iunes M.

Pain or no pain: What are the factors in diabetic neuropathy?
pp. 258-258(1)
Authors: Sorensen L.; McFarlane R.; Molyneaux L.; Yue D.K.

Increased peripheral vascular resistance as a clinical risk factor for developing diabetic nephropathy in Japanese type 2 diabetic patients
pp. 258-259(2)
Authors: Nomura M.; Ohashi M.; Ichida K.; Tukurimichi K.; Tanouchi J.; Yamada Y.; Kadama T.; Abe H.

Behavior of the metabolic and renal function in steadily controlled diabetics with clinical nephropathy
pp. 259-259(1)
Authors: Elbert A.; Ferrari N.; Benito O.; Berezan C.; Diaz A.; Szyszkowsky O.; D'Alessandro J.; Ruiz M.

Insulin, C-peptide and glucagon dynamics in chronic renal failure
pp. 259-259(1)
Authors: Rifaie M.R.; Rasem A.; El-Soutohy H.; Gharieb N.; El Kanishy G.H.

Progression of mild diabetic nephropathy is accompanied by impaired insulin sensitivity and clearance
pp. 259-259(1)
Authors: Svensson M.; Eriksson J.W.

Diabetic nephropathy in Mexico: Associated risk factors and treatment
pp. 260-260(1)
Authors: Morales-Franco G.; Nunez-Patlan R.; Rodriguez-Uribe J.; Gutierrez-Aparicio A.; Rodriguez-Saldana J.; Garcia-Martinez M.A.

Effects of lipo-PGE1 on diabetic nephropathy in the stage of renal failure
pp. 260-260(1)
Authors: Satoh M.; Nogae S.; Watanabe M.; Gotoh M.

Effect of age and sex differences in Urinary Creatinine Excretion (UCE) on measurement of Urinary Albumin/Creatinine Ratio (ACR)
pp. 260-260(1)
Authors: Takahashi C.; Ujihara N.; Tomonaga T.; Babazono T.; Iwamoto Y.

Study of CETP mass in the type 2 diabetic patients with nephropathy
pp. 260-261(2)
Authors: Kawahara R.; Yoshino M.; Miyamae M.; Tanaka A.; Iwamoto Y.

Do the mild renal dysfunction contribute to elevated ANP even for DM patients?
pp. 261-261(1)
Authors: Kimura F.; Sayama H.; Sawada M.; Saito N.; Fujii M.; Shigeta H.; Hasegawa G.; Nakamura N.; Obayashi H.; Nakamura Y.; Kinoshita M.

Prevalence of microalbuminuria in a selected South Indian population - the Chennai Urban Population Study (CUPS)
pp. 261-261(1)
Authors: Mohan V.; Deepa R.; Shanthirani S.; Rema M.

Is urinary glutathione S-transferase a useful marker for monitoring of angiotensin-converting enzyme inhibitor therapy in diabetic nephropathy?
pp. 261-261(1)
Authors: Kosugi E.; Kuboki K.; Higa M.; Kameyama M.; Inokuchi T.

Long-term effect of an aldose reductase inhibitor on development of incipient nephropathy in type 2 diabetes mellitus
pp. 262-262(1)
Authors: Iso K.; Tada H.; Kuboki K.; Tojho Y.; Mogami K.; Inokuchi T.

Evaluation of the medical care in patients with diabetic nephropathy qualified for the dialysis treatment
pp. 262-262(1)
Authors: Idasiak-Piechocka I.; Lochynska K.; Drobnik D.; Oko A.; Czekalski S.

Kidney transplantation in type 2 diabetes mellitus: A case-control comparison with non-diabetic subjects
pp. 262-262(1)
Authors: Boucek P.; Pokorna E.; Saudek F.; Vitko S.; Lanska V.

Effects of acute hyperglycemia and I.V. Furosemide on bradykinin, nitric oxide metabolites and cGMP excretions in type 1 diabetic patients
pp. 262-263(2)
Authors: Pelikanova T.; Simkova R.; Kazdova L.; Jirsa M.; Karasova L.

Evolution of microalbuminuria in type 2 diabetic patients treated with angiotensin-converting enzyme inhibitors
pp. 263-263(1)
Authors: Kamoun H.J.; Blouza S.C.; Abid A.; Ounaissa K.; Miri I.; Nagati K.

The relationship between AMBP and albuminuria in normotensive type 1 diabetics
pp. 263-263(1)
Authors: Smircic-Duvnjak L.; Kovacevic I.; Car N.; Vuckovic S.; Stenzel M.; Cavlovic M.; Metelko Z.

Comparative study of the effects of enalapril and losartan on glomerular size selectivity in hypertensive patients with proteinuria with and without diabetes
pp. 263-263(1)
Authors: Shand B.I.; Scott R.S.; McGregor D.O.; Lewis J.G.; Elder P.A.

Albuminuria, HbA1c and LDL levels are associated with histopathological renal changes in type 2 diabetic patients with micro-macroalbuminuria
pp. 263-264(2)
Authors: Tapia J.; Tencer J.; Alm P.; Willner J.; Torffvit O.

Renal vascular resistance in type II diabetic patients with early diabetic nephropathy
pp. 264-264(1)
Authors: Ljubic S.; Brkljacic B.; Pavlic-Renar I.; Metelko Z.

Extensive evaluation of the renal function by a radioisotopic method in diabetic people: More than an advantage, few limitations
pp. 264-264(1)
Authors: Boldrini E.; Mariani G.; Clerico A.; Forotti G.; Boni G.; Marchini F.; Troilo A.; Matteucci E.; Giampietro O.

Evaluation of serum concentrations of cystatin C and chromogranin A as markers of diabetic nephropathy
pp. 264-265(2)
Authors: Mojiminiyi O.A.; Abdella N.; George S.

Relationship among urinary glycosaminoglycan(GAG) excretion ratio, urinary albumin excretion and macrovascular diseases in patients with Korean type 2 diabetes mellitus
pp. 265-265(1)
Authors: Kim S.Y.; Choi Y.S.; Kim H.; Kim Y.L.; Lee S.J.

Glomerulonephritis in diabetes type 2: Preliminary study of 15 patients with the association of ACEI and antagonists of angiotensin II
pp. 265-265(1)
Authors: Ory J.P.; Didier J.M.; Debieuvre D.; Lebrun C.; Vitrey F.; Bourscheid D.

Anaemia associated with erythropoietin deficiency occurs early in diabetic nephropathy
pp. 265-265(1)
Authors: Bosman D.R.; Winkler A.S.; Marsden J.T.; Macdougall I.C.; Watkins P.J.

Diabetic nephropathy - an eight year analysis at the diabetes clinic of Sindh Institute of Urology and Transplantation (SIUT), Karachi
pp. 265-265(1)
Authors: Jawad F.; Sheikh R.; Naqvi A.; Rizvi A.

Clinical characteristics of diabetic autonomic neuropathy
pp. 266-266(1)
Authors: Ogawa K.; Sasaki H.; Kishi Y.; Yamasaki H.; Yamamoto N.; Hanabusa T.; Nakao T.; Nishi M.; Nanjo K.

Pathogenesis of diabetic neuropathy: Its frequency among diabetic patients with other microvascular complication
pp. 266-266(1)
Authors: Bashi S.; Al-Suwaidan S.D.; Awadha A.; Al-Arfaj A.A.; Al-Jaser S.J.; Al-Jumaah M.

Is autonomous nervous dysfunction an early event in the development of type 2 diabetes?
pp. 266-266(1)
Authors: Lindmark S.; Wiklund U.; Bjerle P.; Eriksson J.W.

Epidemiological assessment of nephropathy in ambulatory cohort of diabetics type 1
pp. 266-266(1)
Authors: Luzniak P.; Czech A.; Taton J.

Cardiovascular autonomic neuropathy in diabetic patients
pp. 267-267(1)
Authors: Gomez P R.E.; Uzcategui O L.R.; Zerpa Y.E.; Yrala O.; Perez V.H.

No strict relationship between peripheral sensory neuropathy and autonomic cardiovascular neuropathy in long-lasting type 1 diabetes
pp. 267-267(1)
Authors: Estrella F.R.; Marchand M.M.; Ernest P.P.; Lefebre P.J.; Scheen A.

Autonomic neuropathy in diabetic subjects
pp. 267-267(1)
Authors: Ferdous H.S.; Pathan M.F.; Liatif Z.A.; Taft J.L.; Colman P.G.

Is ceased vibration sense of the foot a term of macrovascular complications in patients with diabetes?
pp. 267-268(2)
Authors: Vibe-Petersen J.; Lohmann M.; Jorgensen T.; Perrild H.

One year follow up in diabetic patients after surgical treatment of carpal tunnel syndrome
pp. 268-268(1)
Authors: Barada A.; Reljanovic M.; Bilic R.; Kovjanic J.; Metelko Z.

Effect of thioctic acid on diabetic somatic neuropathy
pp. 268-268(1)
Authors: Negrisanu G.; Lefter D.; Bolte B.; Rosu M.; Dabelea D.

Carpal tunnel syndrome in type 2 diabetic patients
pp. 268-268(1)
Authors: Bashi S.; Awada A.; Al-Jumaah M.; Hefernan L.P.; AlSuwaidan S.

Autonomic neuropathy and ABPM behaviour in diabetics: Correlations and suggestions
pp. 268-269(2)
Authors: Forotti G.; Bertini A.; Boldrini E.; Talini E.; Marchini F.; Matteucci E.; Troilo A.; Di Bello V.; Giusti C.; Giampietro O.

Treatment of severe peripheral and autonomic diabetic neuropathy with -lipoic acid (controlled, randomized, open-label trial)
pp. 269-269(1)
Authors: Tankova T.; Koev D.; Dakovska L.

Early autonomic dysfunction evidenced by baroreflex cardiac reflex in type 2 diabetic patients
pp. 269-269(1)
Authors: Voita D.; Vitols A.

Autonomic neuropathy and QT-interval prolongation in nonalcoholic diabetics, nondiabetic alcoholics and in alcoholic diabetic patients
pp. 269-270(2)
Authors: Kempler P.; Keresztes K.; Istenes I.; Kadar E.; Buzasi K.; Hermanyi Z.

Cause - effect relationship between hyperglycaemia and pain perception threshold
pp. 270-270(1)
Authors: Das A.K.; Sharma G.R.K.; S R.

Prevalence of neuropathy using biothesiometry in a selected South Indian population - the Chennai Urban Population Study (CUPS)
pp. 270-270(1)
Authors: Ramu M.; Premalatha G.; Deepa R.; Mohan V.

Normal values of parameters of power spectral analysis of heart rate variability for clinical evaluation of autonomic neuropathy
pp. 270-270(1)
Authors: Hosova J.; Jirkovska A.; Boucek P.; Skibova J.

Simple screening tests for peripheral neuropathy in the diabetes clinic
pp. 270-271(2)
Authors: Perkins B.A.; Olaleye D.; Zinman B.; Bril V.

Early neuropathy and biochemical markers of endothelial dysfunction in young diabetic subjects
pp. 271-271(1)
Authors: Bhowmik N.B.; Parveen S.; Haque A.; Mahtab H.; Rahman A.; Ali L.

Loss of Protective Sensation (LOPS) in NIDDM: Pathogenetic association with atherosclerosis and nephropathy?
pp. 271-271(1)
Authors: Krishnaiengar S.R.; Suma S.; Hegde J.; Basavaraju N.C.; Rama D.V.; Srilakshmi M.A.; Joshi S.; Vinaya A.S.; Narayan G.S.; Dayashankar U.; Sudha B.S.; Mamatha A.H.; Raja G.; Kalpana T.; Sumithra N.; Ishrath N.; Srikanth J.; Mahesh B.A.; Srikanta S.S.; Sharda A.

Insulin resistance, hyperinsulinaemia and salt sensitivity of blood pressure in obese subjects with borderline hypertension
pp. 271-272(2)
Authors: Majkowska L.; Moleda P.; Bohatyrewicz R.; Krzyzanowska B.; Czekalski S.; Pilarksa K.

Morbidity and mortality in diabetic patients with and without hypertension in the North of Portugal
pp. 272-272(1)
Authors: Neves C.; Medina J.L.; Lopes F.

Effects of St. Johns Wort on pain in diabetic and non-diabetic neuropathies
pp. 272-272(1)
Authors: Bach F.W.; Sindrup S.H.; Madsen C.; Gram L.F.; Jensen T.S.

Cardiovascular autonomic function in diabetes mellitus: Effect of glycemic control
pp. 272-272(1)
Authors: Muralidharan M.R.; Chanda A.; Dash R.J.

Time course of risk factors for diabetic foot ulceration
pp. 273-273(1)
Authors: Kastenbauer T.; Sauseng S.; Irsigler K.

Sural nerve haemodynamics in painful and painless neuropathy: Clues to the cause of pain?
pp. 273-273(1)
Authors: Eaton S.E.M.; Harris N.D.; Ibrahim S.; Patel K.A.; Selmi F.; Tesfaye S.; Ward J.D.

Evidence of spinal cord atrophy in diabetic peripheral neuropathy
pp. 273-273(1)
Authors: Eaton S.E.M.; Harris N.D.; Greenwood P.; Wilkinson I.A.; Griffiths P.D.; Rajbhandari S.M.; Tesfaye S.; Ward J.D.

Microcirculatory responses to electrical spinal cord stimulation in painful diabetic neuropathy and other painful conditions
pp. 273-274(2)
Authors: Eaton S.E.M.; Harris N.D.; Selmi F.; Patel K.A.; MacFarlane I.A.; Ward J.D.; Tesfaye S.

Cardiovascular risk factors predict development of diabetic peripheral neuropathy
pp. 274-274(1)
Authors: Tesfaye S.; Chaturvedi N.; Eaton S.E.M.; Ward J.D.; Fuller J.H.; EURODIAB Prospective Complications Study Group

Evaluation of central nerve function in diabetic patients through the analysis of auditory brainstem evoked response (ABER), P300 and autonomic nerve function
pp. 274-274(1)
Authors: Ohgaku S.; Hirai Y.; Kobayashi M.

Peripheral neuropathy in children with diabetes mellitus type 1
pp. 274-274(1)
Authors: Marquez I.; Calderin R.; Sanchez D.; Gimenez I.; Buchaca E.; Fernandez F.; Fiallo R.; Jimenez R.; Rodriguez L.; Gonzalez F.; Lara E.

Amputation profile in the State Institute of Diabetes and Endocrinology (IEDE) in Rio de Janeiro
pp. 275-275(1)
Authors: Baima R.C.S.; Queiroz A.N.P.; Ellinger V.C.M.; Faria R.; Zagury L.

Hypobaric Theraphy (HBT) on diabetics
pp. 275-275(1)
Authors: Lipovec K.; Drinovec J.; Barovic J.; Bagar-Povse M.; Drnovsek R.; Lipovec M.

Prognosis of the critical diabetic foot
pp. 275-275(1)
Authors: Ibarra J.; Salazar S.; Arguedas C.

Seven year survival of diabetics with the first foot lesion
pp. 275-276(2)
Authors: Vozar J.; Waszczuk P.; Adamka J.; Holeczy P.; Molcan T.

Diabetic foot and amputations at the Vuk Vrhovac University Clinic, Zagreb, Croatia, 1991-1999
pp. 276-276(1)
Author: Coce F.

Diabetic foot and high risk of lower limb amputation: Screening protocol
pp. 276-276(1)
Authors: Fisherman R.; Fox D.; Gandini S.; Visco V.; Serra R.; Markmann C.

Surgery or conservative care for the chronic diabetic foot ulcer complicated by osteomyelitis?
pp. 276-276(1)
Authors: Foster A.; Bates M.; Doxford M.; Wilson S.; Walters H.; Fraser S.; Edmonds M.

A new Simple Staging System (SSS) of the diabetic foot
pp. 276-277(2)
Authors: Edmonds M.; Foster A.; Bates M.; Doxford M.

Diabetic foot care - the way forward: A patient's charter and the professional's commitment
pp. 277-277(1)
Authors: Edmonds M.; Van Acker K.; Reisch B.P.; Foster A.; Steering Committee P.o.A.W.G.

Good prognosis in Charcot's arthropathy
pp. 277-277(1)
Authors: Anagnostopoulos D.; Foster A.; Bates M.; Doxford M.; Ryan A.M.; Edmonds M.

A diagnostic protocol for the podologist as an aid in the prognosis of chronic diabetic complications
pp. 277-277(1)
Authors: Balducci S.; De Simon S.; Federici G.; Federici A.; Fallucca F.

Significance of post-operative fever in diabetics with forefoot surgery for osteomyelitis
pp. 277-278(2)
Authors: Bughi S.; Ciobanu V.S.; Kamdar V.A.; Gonzalez F.; Francisco S.L.; Shaw S.J.

Risk factors for ulceration, amputation and death: A long term prospective study
pp. 278-278(1)
Authors: Mingardi R.; Pasqualetti P.; Giurato L.; Lardieri L.; Strazzabosco M.; Erle G.; Menzinger G.; Uccioli L.

The prevalence of foot deformities and neuropathy in people with diabetes in Nellore S. India
pp. 278-278(1)
Authors: Iska A.R.; Chichili R.

Lower Extremity Amputation (LEA) study in Montevideo City, Uruguay 1996
pp. 278-278(1)
Authors: Schinca N.; Acerenza S.; Gil A.D.; Jorge A.M.; Mauro C.; Martinez S.; Kamaid E.; Martin J.

Variation in the incidence of lower extremity amputation in area 7 Madrid, Spain, between 1989-93 and 1994-99
pp. 279-279(1)
Authors: Diaz A.; Duran A.; Familiar C.; Carcia-Torre N.; Moraga I.; Monux G.; Martin-Alvarez P.J.; Charro A.; Maranes J.P.; Calle-Pascual A.L.

Compliance with diabetic foot screening and prophylactic foot care program reduces foot ulcers in diabetic patients
pp. 279-279(1)
Authors: Calle-Pascual A.L.; Benedi A.; Calvo I.; Duran A.; Diaz A.; Calle J.R.; Rubio M.A.; Charro A.; Maranes J.P.

Diabetes-related amputation: Addressing the problem in Fiji
pp. 279-279(1)
Authors: Palmer E.; McGill M.; Bolton T.; Cornelius M.; Yue D.K.

Diabetes mellitus among amputated individuals: Frequency. Chatacteristics and mortality
pp. 279-280(2)
Authors: De Sereday M.; Abdala M.; Basile R.; Bragagnolo J.; Cajide A.; Conejero A.; Damiano M.; Gonzalez C.; Lapertosa S.; Marti M.; Moser M.; Sigal M.; Tesone C.; Tiva L.

Complications after surgical treatment of diabetic (DM) vs. non-DM patients with isolated ankle fracture: A cohort study
pp. 280-280(1)
Authors: Cyran F.; Sheldon L.S.; Gregory G.P.; Nicholas A.; Wayne B.; Alfred B.

Lower extremity amputations in diabetic and non diabetic individuals - a case finding method based on hospital discharge diagnosis
pp. 280-280(1)
Authors: Vaccaro O.; Lodato S.; Mariniello P.; De Feo E.

Risk profile and outcome in an outpatient foot-care center for diabetic patients
pp. 280-281(2)
Authors: Schleiffer T.; Thoma S.; Riemann J.F.

The life-long incidence of foot ulcers in an unselected diabetes population in a Norwegian county. Results from the Nord-Trondelag diabetes survey
pp. 281-281(1)
Authors: Uhlving S.; Cooper J.G.; Midthjell K.; Kruger O.

Impariment of polymorphonuclear leukocyte function and diabetes control in patients with diabetic foot
pp. 281-281(1)
Authors: Jirkovska A.; Fejfarova V.; Hosova J.; Kalanin J.; Striz I.; Skibova J.

Screening test for diabetic foot syndrom - our five years expirience
pp. 281-282(2)
Authors: Piletic M.; Vukelic B.B.; Kavcic Z.

Risk factors for the development of diabetic foot ulcer in Bangladesh
pp. 282-282(1)
Authors: Chowdhury H.K.; Khan M.H.; Wadud J.R.

Injectable silicone and the diabetic foot: A 36-year clinical histopathological report
pp. 282-282(1)
Authors: Balkin S.W.; Kaplan L.

Inpatient survey and the dynamics of the complicated diabetic foot
pp. 282-283(2)
Authors: Nierenberg G.; Eidelman M.; Stein H.

Use of the satin hemostatico (S-100) in the lesions of the diabetic's foot
pp. 283-283(1)
Authors: Ramos C.F.; Martinez D.J.F.; Mendiola S.I.; Mavil L.R.

Comparison of Ankle/Brachial Index with duplex colour doppler scanning in evaluation of peripheral vascular disease in type 2 diabetic patients
pp. 283-283(1)
Authors: Mohan V.; Ravikumar R.; Sanjay R.; Premalatha G.; Deepa R.

Prevalence of peripheral vascular disease in South Indians - the Chennai Urban Population Study (CUPS)
pp. 283-283(1)
Authors: Premalatha G.; Shanthirani C.S.; Deepa R.; Markovitz J.; Mohan V.

The positive epidemiological association between diabetes and peripheral arterial disease: A review of recent prevalence studies
pp. 283-284(2)
Author: Guillot F.B.

The incidence of peripheral arterial disease at long term follow-up is higher in diabetic than in non-diabetic patients: A review of recent epidemiological studies
pp. 284-284(1)
Author: Guillot F.B.

Changes of cutaneous vasomotor response in diabetic patients with and without peripheral arterial occlusive disease
pp. 284-284(1)
Authors: Pirags V.; Tretjakovs P.; Lacis A.; Jurka A.

Preventive effect of an oral PGI₂ analog, beraprost sodium, on vascular edothelial dysfunction in type 2 diabetic patients with asymptomatic peripheral vascular disease
pp. 284-284(1)
Authors: Tojha Y.; Arai M.; Kuboki K.; Mogami K.; Inokuchi T.

Erectile dysfunction in diabetic men: Relationship between quality of life and sindenafil or alprostadil treatment
pp. 284-285(2)
Authors: Turco S.; Guarino G.; Oliviero B.; Turco A.A.; Amodio M.; Annunziata S.; Armentano V.; Gentile S.

Diabetic erectile dysfunction: Vascular or neurological?
pp. 285-285(1)
Authors: Rajbhandari S.M.; Brady L.A.; Harris N.D.; Eaton S.; Tesfaye S.; Ward J.D.

Sildenafil (viagra) improves the QOL of diabetic patients with erectile dysfunction
pp. 285-285(1)
Authors: Suzuki Y.; Maruyama T.; Inukai T.; Negishi K.

The influence of combined vitamin C and E administration on oxidative stress and fibrinolysis in obese type 2 diabetic patients
pp. 285-286(2)
Authors: Skrha J.; Kvasnicka J.

Diabetes mellitus and cardiovascular risk factors inpost-menopausal women
pp. 286-286(1)
Authors: Stolarza Z.Z.S.; Siseles N.N.S.; Gutierrez P.P.G.; Lerner M.M.L.; Gonzalez C.C.G.; Szuster J.J.S.

Study of the QT interval corrected for heart rate in patents with type 2 dibetes mellitus
pp. 286-286(1)
Authors: Sokolov E.I.; Davydov A.L.; Starkova N.T.

Tei-Index is useful in evaluating subclinical cardiac dysfunction in diabetic patients
pp. 286-287(2)
Authors: Tohyo S.; Saito N.

By-pass surgery in coronary artery disease: Effects on insulin sensitivity
pp. 287-287(1)
Authors: Piedrola G.; Garcia-Dominguez E.; Hidalgo C.; Becerra A.; Villar R.; De Luis D.

Normoalbuminuria and cardiovascular risk factors in NIDDM
pp. 287-287(1)
Authors: Rasic-Milutinovic Z.R.; Tica J.; Popin M.; Vujovic M.; Pavicevic M.

QT_c prolongation in type II diabetic patients with hypertension and ischemic heart disease
pp. 287-287(1)
Authors: Khelashvili M.; Kurashvili R.; Akhobadze T.; Dundua M.; Shelestova E.

Efficancy of multiple risk factor control in the management of diabetic macrovasucular complications
pp. 287-288(2)
Authors: Hattori Y.; Suzuki M.; Takeuchi M.; Kimura Y.; Yamazaki Y.; Inada H.; Murase O.; Ito H.; Nawata H.; Orimo H.; Harano Y.; MSDM Group

Myocardial microcirculation abnormalities and sympathetic nerve dysfunction in patients with diabetes mellitus: A nuclear approach with thallium-201 and iodine-123 MIBG
pp. 288-288(1)
Authors: Komori H.; Oi K.; Moroi M.; Okura K.; Yamaguchi T.

Dietary intake and physical activity in tongans - relationship to diabetes and cardiovascular risk factors
pp. 288-288(1)
Authors: Muimuiheata S.; Colagiuri S.; Hussain Z.; Na'ati E.; Colagiuri R.; de Blieck C.; Palu T.

Excessive body weight may not increase mortality in American Indians with diabetes - the strong heart study
pp. 288-289(2)
Authors: Yeh J.; Lee E.T.; Moore W.E.; SHS Investigators

Insulin increases cardiovascular risk factors in non-obese diabetic patients with insulin resistance in Korea
pp. 289-289(1)
Authors: Nam J.; Huh K.-B.; Song Y.-D.; Lim S.-K.; Kim K.-R.; Lee H.-C.

Macrovascular complications in patients with diabetes mellitus - status quo and research of risk factors in our hospital
pp. 289-289(1)
Authors: Nishida K.; Tsujino M.; Takeuchi

Serological markers of acute and chronic infection with chlamydia pneumoniae, cytomegalovirus and helicobacter pylori in diabetic and nondiabetic patients with unstable angina pectoris
pp. 289-290(2)
Authors: Broz J.; Andel M.; Tsevagjav A.; Roubalova K.; Hruba D.; Svandova A.; Bala J.

Diabetes mellitus and ischemic stroke in Mexican patients
pp. 290-290(1)
Authors: Cantu C.; Barinagarrementeria F.; Arauz A.; Escamilla J.

Estimation of multivessel and diffuse coronary artery disease by treadmill exercise test in patients with diabetes mellitus and impaired glucose tolerance
pp. 290-290(1)
Authors: Fujita N.; Tanaka K.; Fujioka M.; Nakagomi A.; Ohta M.; Hashimoto H.

Association of acute phase proteins with carotid intima-medial thickness in offspring of type 2 diabetic patients
pp. 290-290(1)
Authors: Sung Y.-A.; Oh J.Y.; Hong E.S.; Kyung N.H.

Risk factors for cardiovascular disease in diabetic and nondiabetic individuals in a Mexico Southeastern population
pp. 291-291(1)
Authors: Alfaro E.F.; Rojas I.P.; Sanchez V.E.V.; Vazquez J.S.; Herrera G.A.

Structural support significantly improves cardiovascular risk factors in type 2 diabetes in daily practice
pp. 291-291(1)
Authors: Bilo H.J.G.; Ubink-Veltmaat L.J.; Rischen R.O.; de Jong B.M..

Proinsulin and cardiovascular disease risk factors in a native Canadian population
pp. 291-291(1)
Authors: Zinman B.; Hanley A.J.G.; McKeown-Eyssen G.E.; Harris S.B.; Wolever T.M.S.

Effect of weight loss with orlistat on cardiovascular disease risk prediction in type 2 diabetes
pp. 292-292(1)
Authors: Segal K.R.; Lucas C.; Hauptman J.; Hollander P.

WHO cardiovascular questionnaire and resting ECG are predictors of cardiovascular events in type 2 diabetic patients: A 6-year prospective study
pp. 292-292(1)
Authors: Neto A.F.P.R.; Azevedo M.J.; Ludwig R.; Copstein E.; Ferronato M.E.; Pedroso L.L.; Nunes A.; Beck M.O.; Gross J.L.

Serum leptin during hormone replacement therapy in women with coronary artery disease
pp. 292-292(1)
Authors: Os I.; Westheim A.; Abdelnor M.; Birkeland K.

Electrocardiographic abnormalities and dyslipidaemia in Jamaican diabetics
pp. 293-293(1)
Author: Wright-Pascoe R.A.

Is the activity of VWF increased in type II diabetes mellitus?
pp. 293-293(1)
Authors: Park K.E.J.; Favaloro E.J.; Chambers K.D.; Boyages S.C.; Koutts J.

Clinical usefulness of brain natriuretic peptide to assess the diabetic cardiac disorder
pp. 293-293(1)
Authors: Himei H.; Matsuoka T.

Coronary levels of endothelin I and angiotensin II and intraluminal coronary diameters of diabetics with coronary disease
pp. 293-294(2)
Author: Mundo J.

Pre-Obesity in WHO classification involves metabolic syndrome in Japanese
pp. 294-294(1)
Authors: Ota T.; Takamura T.; Kobayashi K.-I.; Hirai N.; Hirose S.

Lispro insulin infusion for glycemic control post-coronary artery bypass grafting - Indian pilot study
pp. 294-294(1)
Authors: Joshi S.R.; Joshi S.S.; Shah P.S.; Dongre R.; Narayanan T.S.

The evaluation of the levels of serum homocysteine and von Willebrand factor in type 2 diabetes
pp. 294-294(1)
Authors: Orlowska-Kunikowska E.; Kolcowa O.; Owczarzak A.; Krupa-Wojciechowska B.; Lysiak-Szydlowska W.

The success rate of percutaneous coronary revascularisation procedures in diabetic patients
pp. 294-295(2)
Authors: Mrevlje B.; Pecan Z.; Kranjec I.

Menopause accelerates early carotid atherosclerosis in non-diabetic subjects
pp. 295-295(1)
Authors: Hayaishi R.; Yamasaki Y.; Otoshi K.; Hoshi A.; Katagami N.; Kajimoto Y.; Kubota M.; Node K.; Hori M.

Platelet aggregation and plaque formation of carotid artery in type 2 diabetic patients
pp. 295-295(1)
Authors: Hiyoshi T.; Hisano N.; Komatsu J.; Akasu F.; Yoshitsugu M.

Association of coronary atherosclerosis and carotid wall thickness
pp. 295-296(2)
Authors: Ahn C.; Kim D.; Nam J.; Song Y.; Cha B.; Lim S.; Lee H.; Huh K.

Normoalbuminuria and cardiovascular risk factors in type 2 diabetic patients
pp. 296-296(1)
Author: Rasic Z.R.

Is silent myocardial ischemia in diabetes mellitus attributable to diffuse coronary artery disease? Evaluation with ²⁰¹TI stress test and coronary angiogram assessed by the extent score
pp. 296-296(1)
Authors: Fujioka M.; Kichol H.; Fujita N.; Tanaka K.; Kusama Y.; Ohta M.; Hashimoto H.; Takano T.

Postprandial hyperglycemia but not fasting blood glucose is a risk factor for cardiovascular death in type 2 diabetes: The diabetes intervention study (DIS)
pp. 296-296(1)
Authors: Hanefeld M.; Julius U.; Schmechel H.; Schwanebeck U.

Predictors of ten-year mortality in type 2 diabetes in Canterbury, New Zealand
pp. 296-297(2)
Authors: Florkowski C.M.; Scott R.S.; Coope P.A.; Graham P.J.; Moir C.L.

Serious and frequent asymptomatic coronary atherosclerosis in young type 1 diabetes patients
pp. 297-297(1)
Authors: Larsen J.R.; Brekke M.; Arnesen H.; Hanssen K.F.; Dahl-Jorgensen K.

The prevalence of cardiovascular risk factors and disease in type 2 diabetic patients of three different ethnic origins in Northwestern Israel
pp. 297-297(1)
Author: Herskovits A.T.

Cardiovascular events in hyperglycemic subjects from India
pp. 297-298(2)
Authors: Shelgikar K.M.; Raut K.N.; Naik S.S.; Joglekar C.V.; Sayyad M.G.; Yajnik C.S.

Risk factors for ischemic heart disease and cerebral thrombosis in diabetes in Japan: For 10 years retrospective study
pp. 298-298(1)
Authors: Tomono S.; Utsugi T.; Ohyama Y.; Uchiyama T.; Ito H.; Ito M.; Mori Y.; Kawazu S.

Risk factors for cardiovascular disease and type 1 diabetes mellitus
pp. 298-298(1)
Authors: Noutsou M.M.; Thanopoulou A.C.; Kofinis A.J.; Tountas C.D.; Papazoglou N.A.; Karamanos B.G.

Plasma homocysteine in women with coronary artery disease and elevated blood glucose or diabetes mellitus is not affected by hormone replacement therapy
pp. 298-298(1)
Authors: Os I.; Westheim A.S.; Abdelnor M.; Brekke M.

Endothelial dysfunction due to diabetes: Evidence from Sheffield prospective diabetes study
pp. 299-299(1)
Authors: Rajbhandari S.M.; Dent M.T.; Plater M.E.; Harris N.D.; Tesfaye S.; Ward J.D.

Asymptomatic carotideal atherosclerosis in type 2 diabetes, hyperlipemia, obesity and postmenopausea
pp. 299-299(1)
Authors: De La Torre W.; Figueroa J.; Chicaiza M.

Transversal analysis of clinical, metabolic and vascular associated factors to type 2 Diabetes Mellitus (DM) in the Andean region
pp. 299-299(1)
Authors: De La Torre W.; Lopez G.; Romero L.; Bernal N.

Correlation between early and late epileptic seizures and diabetes mellitus during and after stroke
pp. 299-300(2)
Authors: Alajbegovic A.; Kantardzic D.; Alajbegovic S.; Bratic M.; Suljic E.; Resic H.

Increased levels of soluble intercellular adhesion molecule-1 are associated with progression of ischemic stroke in middle-aged and elderly diabetic patients
pp. 300-300(1)
Authors: Kawamura T.; Umemura T.; Sano T.; Sakamoto N.; Nakamura J.; Hotta N.

Obesity, diabetes and other cardiovascular risk factors in the Ayoreos of the Paraguayan Chaco
pp. 300-300(1)
Authors: Benitez A.; Ruffinelli J.V.; Echague G.; Medina U.; Arias A.R.; Azorero R.M.

Impact of obesity on the cardiovascular risk factors in the subpopulation with diabetes mellitus type 2
pp. 300-300(1)
Authors: Luzniak P.; Czech A.; Taton J.

Influence of glycyemic control on size of myocardial infarction and long-term survival of type 2 diabetic patients
pp. 300-301(2)
Authors: Nauck M.A.; Deifusz S.; Klamann A.; Sarfert P.; Schmiegel W.

Plasma homocysteine levels and atherosclerotic diseases in patients with type 2 diabetes mellitus
pp. 301-301(1)
Authors: Yoshitsugu M.; Hisano N.; Hiyoshi T.; Akasu F.

Glycoprotein IIb/IIIa Polymorphism in type-2 diabetic patients with and without myocardial infarction
pp. 301-301(1)
Authors: Eibl N.; Streit G.; Krugluger W.; Hopmeier P.; Schernthaner G.

Dietary fat intake and coronary heart disease events in subjects with type 2 diabetes
pp. 301-302(2)
Authors: Ronnemaa T.; Soinio M.; Hakala P.; Lehto S.; Laakso M.

Relationship between intimal-medial thickness of carotid artery and plasma levels of vascular endothelial growth factor or platelet-derived growth factor in type 2 diabetic patients
pp. 302-302(1)
Authors: Inukai T.; Takebayashi K.; Tayama K.; Aso Y.; Takemura Y.

Predictors of 10-year mortality in patients with type 2 diabetes mellitus
pp. 302-302(1)
Authors: Gall M.-A.; Knudsen E.; Hougaard P.; Borch-Johnsen K.; Parving H.-H.

Asymmetry of common carotid artery velocity is a marker for cardiovascular disease in type 2 diabetic patients
pp. 302-302(1)
Authors: Nakano H.; Okazaki K.; Suzuki T.; Oba K.

Prevalence of coronary artery disease in a selected south Indian population - the Chennai Urban population study (CUPS)
pp. 303-303(1)
Authors: Mohan V.; Premalatha G.; Shanthirani C.S.; Deepa R.

Hyperinsulinemia and coronary artery disease among South Indian Population - the Chennai urban population study (CUPS)
pp. 303-303(1)
Authors: Deepa R.; Shanthirani C.S.; Premalatha G.; Mohan V.

Newer risk factors for coronary artery disease in South Indian subjects
pp. 303-303(1)
Authors: Deepa R.; Velmurugan K.; Karkuzhali K.; Dwarakanath V.; Mohan V.

Absence of association between serum homocysteine levels and coronary artery disease in South Indians
pp. 303-303(1)
Authors: Deepa R.; Velmurugan K.; Karkuzhali K.; Dwarakanath V.; Mohan V.

Intimal medial thickness of the carotid artery in type 2 diabetic patients with coronary artery disease
pp. 304-304(1)
Authors: Mohan V.; Rajmohan L.; Deepa R.; Karkuzhali K.; Premalatha G.

An audit tool to assess standards of care in patients with both diabetes and cardiovascular disease
pp. 304-304(1)
Authors: Panja S.; Sailesh S.; Roxburgh M.; Patel V.

Audit: Do patients with type II diabetes requiring insulin achieve the recommended treatment targets for macrovascular disease risk factors?
pp. 304-304(1)
Authors: Hassanein M.M.; Finshwick H.; Taylor M.A.

Risk variables for coronary artery disease in Asian Indians
pp. 304-305(2)
Authors: Ramachandra A.; Sathyamurthy I.; Snehalatha C.; Satyavani K.; Sivasankari S.; Misra J.; Girinath M.R.; Viswanathan V.

Radioisotopic evaluation of the prevalence of silent coronary artery disease in high-risk diabetic patients
pp. 305-305(1)
Authors: De Micheli A.; Bordone C.; Castagnola F.; Cataldi L.; Costa R.; Della Rovere F.; Erba P.; Faveto M.; Giunta L.; Mariani G.; Villa G.; Vinci P.

Subclinical macrovasculopathy in non-diabetic subjects: Its association with blood glucose levels
pp. 305-305(1)
Authors: Cintora H.O.; Iurescia M.; Machain M.; Gonzalez C.D.

Cardiovascular prevention in type 2 diabetes mellitus, Are we succeeding?
pp. 305-306(2)
Authors: Fegan G.; Ward D.; Clarke L.; MacLeod K.; Hattersley A.

Morbidity and mortality for acute myocardial infarction and diabetes mellitus
pp. 306-306(1)
Authors: Bajuk N.B.; Mikolic R.

''High-Normal'' fasting and postprandial blood glucose levels in patients with coronary heart disease who have normal glucose tolerance
pp. 306-306(1)
Authors: Hosszufalusi N.; Panczel P.; Janoskuti L.; Prohaszka Z.; Karadi I.; Romics L.

The prognosis and complications in diabetic patients after aortocoronary bypass surgery
pp. 306-306(1)
Authors: Charvat J.; Stritesky M.; Vecer J.; Vanek I.; Kvapil M.

Serum homocysteine (HCT) in type 2 diabetes (DM2): Relationship with metabolic control (MC) and macroangiopathy (MA)
pp. 306-307(2)
Authors: Libman J.; Polenta M.; Bessone G.; Menichini A.; Libman A.M.

Microalbuminuria is a strong risk factor for atherosclerosis in various degrees of glucose tolerance
pp. 307-307(1)
Authors: Temelkova-Kurktschiev T.; Koehler C.; Henkel E.; Schaper F.; Hanefeld M.

Evaluation of cerebral blood flow, in type 2 diabetic without any severe hipoglucemia and central nervous damage history
pp. 307-307(1)
Authors: Jadzinsky M.N.; Garcia C.S.; Vivante H.A.; Croci A.H.

Homocysteine concentration in men with coronary artery disease and the disturbances of carbohydrate metabolism
pp. 307-307(1)
Authors: Kowalska I.; Telejko B.; Bachorzewska-Gajewska H.; Prokop J.; Musial W.; Kochman W.; Kinalska I.

Aspirin does not influence an increased availability of platelet factor 3 in type 2 diabetic patients
pp. 307-308(2)
Authors: Telejko B.; Samson J.; Tomasiak M.; Kowalska I.; Kinalska I.

Oxidative stress in families of type 1 diabetic patients
pp. 308-308(1)
Authors: Matteucci E.; Cinapri V.; Quilici S.; Forotti G.; Giampietro O.

Serum lipoprotein(a) as a risk factor for coronary heart disease in Kuwaiti type 2 diabetic patients
pp. 308-308(1)
Authors: Abdella N.A.; Mojiminiyi O.A.; Akanji A.O.; Moussa M.A.

Homocysteine and its association with diabetic complications in Kuwait Arab subjects
pp. 308-309(2)
Authors: Abdella N.A.; Mojiminiyi O.A.; Akanji A.O.; Moussa M.A.

Endothelin-1 levels are related to nocturnal decline of blood pressure in normotensive patients with type-2 diabetes
pp. 309-309(1)
Authors: Streit G.; Eibl N.; Dossenbach A.; Hopmeier P.; Schernthaner G.

Mini-dose glucagon rescue of impending hypoglycemia in children and adolescents with diabetes during episodes of gastroenteritis and/or poor oral intake
pp. 309-309(1)
Authors: Haymond M.W.; Schreiner B.

Identification of patients with unrecognised hypoglycaemia by a mathematical model of the carbohydrate metabolism assessed by the minimed subcutaneous glucose sensor
pp. 309-310(2)
Authors: Hejlesen O.K.; Plougmann S.; Cheyne E.; Kentish J.; Kerr D.; Cavan D.A.

The D allele of the ACE genotype confers susceptibility to severe hypoglycaemia in type 1 diabetes
pp. 310-310(1)
Authors: Pedersen-Bjergaard U.; Agerholm-Larsen B.; Pramming S.; Thorsteinsson B.

High serum ACE is associated with high rate of severe hypoglycaemia in type 1 diabetic patients
pp. 310-310(1)
Authors: Pedersen-Bjergaard U.; Agerholm-Larsen B.; Pramming S.; Thorsteinsson B.

The effect of oral glucose on responses to hypoglycaemia: A possible role for the portal glucose sensor?
pp. 310-310(1)
Authors: Smith D.; Pernet A.; Reid H.; Bingham E.; Rosenthal M.; Umpleby M.; Amiel S.A.

Systemic, but not local, propranolol infusion blocks hypoglycemic muscular insulin resistance
pp. 310-311(2)
Authors: Hoffman R.P.; Sinkey C.A.; Phillips B.G.

Impaired renal response contributes to defective glucose counterregulation in type 1 diabetes
pp. 311-311(1)
Authors: Cersosimo E.; Ferretti J.; Sasvary D.; Garlick P.

Altered counterregulatory response to hypoglycaemia in type 2 diabetes: Implications for clinical management
pp. 311-311(1)
Authors: Spyer G.; Hattersley A.; Mitchell K.; Ayres S.; Amiel S.; MacLeod K.

Hypoglycemias without warning and lispro insulin
pp. 311-312(2)
Authors: De Oliveira R.F.C.; de Oliveira R.B.C.C.

The first clinical experience and effectiveness of atorvastatin - lipid lowering agent use for diabetes patients with dyslipidemia in Latvia
pp. 312-312(1)
Author: Rasa I.

Decrease of oxidatively modified LDL during long-term LDL-apheresis treatment
pp. 312-312(1)
Authors: Mrzljak V.; Turk Z.; Pavkovic P.; Metelko Z.

Relationship between insulin resistance and fasting serum lipids and uric acid concentrations in diabetics
pp. 312-312(1)
Authors: Nakajima S.; Sanjiki S.

Atorvastatin (A), although minimally increasing LDL size does reduce small, dense LDL particle mass similar to niacin (N) and Niaspan (NS) in diabetic patients (DPs)
pp. 312-313(2)
Authors: Pan J.; Lin M.; Chan E.; Charles M.A.

The improvement of plasma lipid profile after substitution of red meat with chicken is due to a reduction of saturated fatty acids intake
pp. 313-313(1)
Authors: Mello V.D.F.; Moulin C.C.; Zelmanovitz T.; Paggi A.; Hoeffel A.; Leitao C.; Juca C.; Perassolo M.S.; Azevedo M.J.; Gross J.L.

Pioglitazone improves the lipid profile in patients with type 2 diabetes
pp. 313-313(1)
Authors: Braithwaite S.; The Pioglitazone 001 Study Group

Lp (a) concentrations in obese prediabetic subjects
pp. 314-314(1)
Authors: Caparevic Z.V.; Kostic N.D.; Jelic S.D.; Bojkovic G.M.

Impairment of beta cell secretion determines lipid profile in severe obesity
pp. 314-314(1)
Authors: Geloneze B.; Pareja J.C.; Repetto E.M.; Costa A.G.; Tambascia M.A.